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The continuous progress of printing technologies over the past 20 years has fueled the 19 
development of a wide plethora of applications in materials sciences, flexible electronics and 20 
biotechnologies. More recently, printing methodologies have started up to explore the world of 21 
Artificial Biology, offering new paradigms in the direct assembly of Artificial Biosystems 22 
(small condensates, compartments, networks, tissues and organs) by mimicking the result of 23 
the evolution of living systems and also by redesigning natural biological systems, taking 24 
inspiration from them. This recent progress is reported in terms of a new field here defined as 25 
Printing Biology, resulting from the intersection between the field of printing and the bottom 26 
up Synthetic Biology. Printing Biology explores new approaches for the reconfigurable 27 
assembly of designed life-like or life-inspired structures. This review presents this emerging 28 
field, highlighting its main features, i.e. printing methodologies (from 2D to 3D), molecular ink 29 
properties, deposition mechanisms, and finally the applications and future challenges. Printing 30 
Biology is expected to show a growing impact on the development of biotechnology and life-31 
inspired fabrication. 32 
 33 
 34 
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 1 
1. Introduction 2 
Printing technologies have been very important for the recent development of human mankind, 3 
since from the invention of the printing press (15th century), they allow producing and 4 
distributing written texts among the masses. A fundamental milestone in this process was the 5 
invention of lithography in 1796 by Alois Senefelder, that consisted in transferring images onto 6 
paper by using lithographic limestone plate masks and inks.[1] This approach was optimized 7 
during the following centuries, permitting to pattern materials from polymer coated plates or, 8 
by transferring the pattern onto flexible rubber blankets, as in the offset lithography.[2] The 9 
invention of soft lithography in 1993 marked another crucial step, since it defined the possibility 10 
to use low-cost elastomeric stamps, allowing printing molecular inks onto large areas at high 11 
resolution and low cost.[3]  12 
Since the 21th century, printing technologies gained a significant impact also in the context of 13 
thin-film and plastic electronics by employing molecular inks onto flexible supports (such as 14 
plastics), at low cost and low temperature in comparison to conventional silicon-based 15 
electronics manufacturing.[4] Molecular printing includes both 2D and 3D printing that can be 16 
carried out according to contact and non-contact methodologies.[5] In contrast to the non-17 
contact approaches (e.g., Inkjet Printing), the contact ones come in physical contact with the 18 
substrate (e.g., Pin Printing, Microcontact Printing and Dip Pen Nanopatterning). In addition to 19 
materials sciences, the development of printing methodologies has fueled also different bio-20 
related fields (genomics[6] proteomics,[7] biochips[8,9]) and more recently are intersecting the 21 
field of Synthetic Biology by developing different artificial biosystems. 22 
On this respect. Synthetic Biology originated from the 20th century, with the studies on artificial 23 
life assemblies made in the lab in the form of simple protocells. In particular, the term Synthetic 24 
Biology was firstly employed by the Stéphane Leduc's publication of “Théorie physico-25 
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chimique de la vie et générations spontanées” in 1910.[10] In 1961, Jacob and Monod 1 
investigated the cellular regulation by molecular networks from the lac operon in E. coli.[10] In 2 
1978, the term Synthetic Biology was used to describe the discovery of restriction enzymes.[11] 3 
In 2010, the first bottom-up example of fabrication of a self-replicating synthetic bacterial cell 4 
was demonstrated from DNA sequences of Mycoplasma myciodes delivered into a host 5 
Mycoplasma capricolum cell[12] and, as an example of a more recent breakthrough in this field, 6 
Chin et al. realized a variant artificial form of E. coli in 2019.[13] Thus, actually Synthetic 7 
Biology is recognized as the emerging multidisciplinary field that employs engineering 8 
approaches to build up artificial biosystems[14] including biomimicking (life-like or life-9 
inspired) components and systems [15–17]. On this respect, Synthetic Biology employs two 10 
different approaches, i.e. the so called top-down and bottom-up.[18] The first refers to 11 
experimental methods that derive from metabolic and genetic engineering for adding foreign 12 
biomolecular elements or modules to living cells (typically DNA fragments or entire genes). 13 
The bottom-up approach combines molecular or biomolecular building blocks in vitro to obtain 14 
ordered and functional biosystems. The smallest artificial biosystems may be described by 15 
nanoscopic condensates showing biological functions or membrane-free artificial 16 
compartments. Typical examples include solid-supported dense DNA phases[19] colloidal 17 
systems from inorganic nanomaterials,[20] clay-based systems,[21] coacervates or soft colloidal 18 
microgels capturing macromolecular systems (DNA,[22,23] RNA,[24] peptides,[25] proteins[26]). 19 
These assemblies permit also to shed light on the role of the prebiotic organization of key 20 
structural building blocks before the presence of membrane-separated systems;[27] in particular, 21 
it has been crucial the role of clays and layered double hydroxides[28–30] in the molecular origin 22 
of life on Earth, and also on the role of liquid/liquid phase separation in the complex 23 
organization via the condensation of the molecular machineries inside eukaryotic cells leading 24 
to membranelless organelles.[31–33]  25 
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By increasing complexity, bottom-up synthetic biology develops artificial compartments 1 
enclosed by  nanoscopic membranes including  assemblies enclosed by lipidic or polymeric 2 
membranes (liposomes[34] and polymersomes[35], respectively), oil-in-water[36–39] and water-in-3 
oil[40] emulsions stabilized by amphiphilic membranes, inorganic nanoparticles 4 
(colloidosomes[41,42]) or protein-polymer capsules (proteinosomes[43,44]). The presence of a 5 
permeable membrane may result in inter-compartments communication.[45] Finally, bottom-up 6 
Synthetic Biology provided insights in tissue engineering[46] including 3D-patterned artificial 7 
networks responsive to environmental stimuli.[47]  8 
Interestingly, the engineering of the above small condensates and artificial compartments may 9 
be important also for understanding the abiogenesis processes (origin of life), the living systems 10 
being believed to have evolved from primitive sub-micron sized protocells.[48–50] Indeed, as a 11 
result of this evolution, eukaryotic living cells experience volumes typically of picoliters (pL; 12 
tens of microns in diameters) and are characterized by a highly crowded molecular environment 13 
within a confined space.[19] This is possible since cellular systems have further localized the 14 
reaction components into femtoliter (fL; microns) scale compartments like membrane-bound 15 
organelles, as the nucleus storing the genetic instruction and the Golgi apparatus or the 16 
endoplasmic reticulum for protein trafficking. An important role into the cells is also played by 17 
membraneless organelles – i.e. protein and nucleic acid condensates rapidly 18 
assemble/disassemble in response to stimuli-  such as the nucleoli (RNA-protein granules), the 19 
Cajal bodies, P granules,[33,51] [52–54] In some cases, biomolecular condensates can undergo 20 
functional liquid-to-solid transitions as for the microtubule-mediated chromosome 21 
segregation.[55] Further downsizing to attoliters (aL; hundreds of nanometers) leads to the 22 
production of systems devoted to cellular communication (synaptic vesicles, exosomes and 23 
other ones).[56] 24 
  
5 
 
By considering the fabrication of the above artificial biosystems, the printing approaches 1 
experience their capability to generate biological complex assemblies over an extraordinary 2 
wide size range (from primitive organelles to tissues and organs) by software-defined programs. 3 
Thus, these approaches are very innovative and convenient with respect to those others 4 
currently reported in literature. On this respect, patterning approaches based on the 5 
microelectronics manufacturing techniques or the Electron Beam Lithography can operate only 6 
on solid substrates, are expensive and time consuming. Moreover, among the most conventional 7 
approaches the direct water-in-oil emulsification lacks in programmability and size control,[57] 8 
DNA nanotechnology suffers from complex implementation  and high cost,[58] and microfluidic 9 
approaches[59,60] (T-junction, flow focusing and coflowing)[61] are not programmable and are 10 
limited in controlling  droplet size and composition.[62] As to microfluidics, Gañán-Calvo and 11 
collaborators have shown the possibility to produce attoliter droplets, by employing advanced 12 
platforms based on electrostatic or hydrodynamic flow focusing.[59]  13 
In this scenario, the employment of printing approaches for the development of the bottom-14 
up Synthetic Biology is here referred to the new field of Printing Biology, defined as this 15 
research segment dealing with the direct assembly of life-like and life-inspired artificial 16 
biosystems from the nano- to the macro-scales by the additive delivery of molecular inks onto 17 
solids or into liquids. Differently from the well-known field of Bioprinting which leverages 18 
computer-aided printing processes for patterning and assembling living cells and other 19 
biomaterials with a predetermined 2D or 3D organization to realize cellularised structures, 20 
aiming to recapitulate natural tissue physiology for applications in cell biology, 21 
pharmacokinetics and regenerative medicine,[63] Printing Biology aims to synthetize even new 22 
forms of life-like or life-inspired systems from the nano to the macro-scale which may show 23 
cutting-edge properties favoring the development of emerging applications in Biotechnology. 24 
In addition, Printing Biology employs inks of both natural and artificial origin, such as DNA, 25 
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proteins, lipids, carbohydrates and synthetic polymers, leading to the bottom-up assembling of 1 
nano- to macro-scale artificial biological systems. 2 
This review highlights just the key features of Printing Biology specifically referring to the 3 
engineering of those artificial biosystems inspired from the origin and the evolution of living 4 
systems by programming compartment sizes, compositions, physicochemical properties and, 5 
eventually, the collective behavior of assembles mimicking biological networks, tissues and 6 
organs (Figure 1).  7 
In order to guide the reader, this Review is divided into different sections. After the 8 
introduction, the section 2 deals with the fundamentals of the physics of droplet formation and 9 
dispensing onto solid and liquid surfaces, along with the details of the most relevant molecular 10 
inks used in Printing Biology. In section 3, we describe the inks based on the most relevant 11 
molecular building blocks (nucleic acids, proteins, phospholipids, carbohydrates). Then, 12 
section 4 and 5 refers to the Printing Biology fabricated biosystems on solids and into liquids. 13 
Finally, in the conclusions the challenges and perspectives of the fields are provided.  14 
2. Printing Molecular Inks 15 
2.1 Droplet formation: defining the operative parameters  16 
Since many printing approaches are involved in the fabrication of artificial biosystems, it is 17 
necessary to understand the physicochemical principles that regulate the droplet formation 18 
processes and the compatibility with solutions containing biomolecules, hereafter defined 19 
“molecular inks” and the receiving surface onto which the droplets are printed, considering its 20 
physical state (solid or liquid). 21 
In general, the molecular ink droplet can be conveniently described by three dimensionless 22 
numbers, the Weber number We, the Ohnesorge number Oh and the Reynolds number Re, 23 
defined as follows: 24 
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𝑊𝑒 = (𝜌𝐷𝑉2) 𝜎⁄                                                          (1) 1 
𝑂ℎ = µ (𝜌𝜎𝐷1 2⁄ )⁄                                                          (2) 2 
𝑅𝑒 = 𝑊𝑒1 2⁄ 𝑂ℎ⁄                                                           (3) 3 
where ρ is the density (kg/m3) of the fluid, D and V are respectively, the diameter (m) and the 4 
velocity (m/s) of the droplet, μ is the dynamic viscosity (mPa·s) and σ is the fluids surface 5 
tension (mN/m). The We number is defined as the ratio between the inertial and the surface 6 
tension forces, the Oh number relates the viscous force to the inertial and the surface tension 7 
forces, and finally the Re number is the ratio of inertial forces to viscous forces. These numbers 8 
are employed to quantify the droplets formation conditions and the droplet impact process onto 9 
the substrate of interest (see below).  10 
As aforementioned, the printing technologies can be divided in contact and non-contact 11 
approaches, by considering if the printing device comes in physical contact with the receiving 12 
substrate (see Figure 2). The most relevant contact printing approaches relevant for Printing 13 
Biology are those derived from Pin Printing,[64] Microcontact Printing,[65] Dip Pen 14 
Nanolithography,[66] Polymer Pens,[67] Hard-Tip Soft-Spring Lithography;[68] on the other hand, 15 
the non-contact approaches of interest for Printing Biology can be considered the following: 16 
Inkjet,[69] Electrohydrodynamic[70] and Pyro-Electrohydrodynamic Printing.[71] 3D and 4D 17 
Printing techniques[72,73] embrace a range of different specific approaches, spanning between 18 
contact (e.g. extrusion/fused deposition) and non-contact methods (e.g. jetting and inkjet 19 
printing), thereby it is fair to present the two separate ensembles of contact techniques and non-20 
contact ones.    21 
As far the contact approaches are concerned, the printing device can be considered not quite 22 
different from a pen. The molecular ink can be deposited from the pen to the receiving surface 23 
by molecular diffusion or by flowing to the surface. The first example of this strategy has been 24 
reported for high-resolution nanoscale patterning by Dip Pen Nanolithography (DPN). In 25 
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particular, for the DPN printing process it is fundamental to distinguish the printed fluids in 1 
diffusive inks and liquid inks. The former ones consist in molecules physically adsorbed on the 2 
tip surface, while the latter are actual liquid solutions containing the material to pattern. The 3 
two different kinds of inks are characterized by different mechanisms of material transport from 4 
the tip onto to the support. Concerning the diffusive inks deposition (Figure 3A), it can be 5 
described by a numerical/analytical model, which relies on a two-dimensional diffusion from a 6 
source (i.e. the tip).[74] The model assumes that the molecular flux from the tip to the receiving 7 
surface creates a concentration gradient around the tip, triggering further molecules diffusion 8 
over the region already occupied by other ink molecules. The transport mechanism takes 9 
advantage of the water meniscus spontaneously condensed in between the tip and the receiving 10 
surface, resulting in a liquid bridge for the diffusion of molecules towards the solid surface. The 11 
lateral size of the deposited feature is at the nanoscale resolution. This analytical model enables 12 
to describe the radial deposition from the tip as a function of tip-surface dwell time, following 13 
this simple expression:   14 
𝑅(𝑡)2 = 4𝐷𝑡 · 𝑙𝑛 [
𝑛
4𝐷𝜋𝜌
]                                                          (4) 15 
where t (s) is the dwell time contact, ρ the monolayer density (1/ Å), D (µm2/s) is the coefficient 16 
of diffusion, n (1/s) is the number of ink molecules deposited per unit time. This model 17 
highlights the highly diffusional nature of self-assembly diffusion process which make this 18 
process dependent on the molecular size and the characteristics of the receiving surface.  19 
The second case comprises the liquid inks, much more commonly used, that are kept in the 20 
liquid state over all the printing process (Figure 3B). The liquid ink deposition by DPN relies 21 
on a different mechanism with respect to the diffusive ones, because of the presence of solvent 22 
molecules in the droplet. Accordingly, the solvent can be described as a molecular carrier that 23 
allows molecules to be deposited to the receiving surface. In particular, the droplet deposition 24 
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is triggered by the Laplace pressure gradient between the ink-tip (ΔPtip) and the ink-air (ΔPm) 1 
menisci. The Laplace pressure is defined as the pressure difference the curved surface of a 2 
liquid at the boundary between air and liquid and can be expressed by the Young–Laplace 3 
equation: 4 
∆P =  σ (
1
𝑅1
+
1
𝑅2
)                                                           (5) 5 
where R1 and R2 are the major curvature radii and σ is the surface tension.  In order to deposit 6 
the droplet to the surface, the Laplace pressure at the tip/meniscus interface has to be larger 7 
than that at the meniscus/substrate one.[75–77] The difference between the Laplace pressures 8 
arises from different curvatures of the liquid/air interface at the tip/meniscus interface as 9 
compared with that at the meniscus/substrate one. The size growth of the droplet continues until 10 
a saturation is observed due to the variation with time of the droplet surface curvature at the 11 
meniscus/substrate and tip/meniscus. As reported by models,[78,79] the ink viscosity depletes the 12 
driving deposition energy by the Laplace pressure gradient, slowing down the growth rate. 13 
When the ink-loaded pen approaches the surface, a liquid meniscus is formed, composed of the 14 
liquid ink itself in addition to water molecules from the atmosphere. When the tip is pulled 15 
away from the surface, it is subjected to an attractive capillary force, which goes to zero at a 16 
certain distance at which the water meniscus breaks, resulting in a droplet whose volume is 17 
usually at the micron scale. In the case of liquid ink deposition by soft polymeric based pens, 18 
such as in Microcontact Printing (µCP) or in Polymer Pen Lithography (PPL), it is again the 19 
difference between Laplace pressures at the tip and the surface that main factor that drives the 20 
deposition on the receiving surface (Figure 3C). Along with this, the force exerted by the pens 21 
on the surface further permits to increase the lateral size of the deposited droplet up to the 22 
micron scale.[67] 23 
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As far as the non-contact approaches are concerned, it is known that the droplet size is, in 1 
principle, physically constrained by the size of the orifice/channel from which the droplet is 2 
generated[80] and from the abovementioned physicochemical properties of the ink, especially 3 
viscosity and surface tension. The possibility to print biomolecules-rich aqueous droplets at the 4 
living cell scale (pL-scale) or even at the sub-cellular scale (fL-scale) becomes a crucial 5 
parameter that can favorably permit the application of these techniques in Printing Biology. 6 
Note that several reports have demonstrated the possibility to tune droplet formation dynamics 7 
by using a set of different boundary conditions that involve hydrodynamic droplet dispensing 8 
under electrical field guiding,[81] droplets production within liquid environments,[82] satellite 9 
droplets printing,[83] breaking up in a double-orifice system,[84] reducing the impulse duration 10 
time.[85] Other approaches that can reach sub-cellular scale resolution include 11 
electrohydrodynamic,[70] or pyroelectrodynamic dispensing.[71] One hurdle of these approaches 12 
is that they are associated with significant shear/compression stresses that can ultimately lead 13 
to the alteration of the biomolecular structures and functions.  14 
In general, the rheological characteristics of molecular inks are usually tuned by the presence 15 
of biocompatible additives, such as viscous high-boiling point co-solvents. Glycerol is among 16 
the most used co-solvents in ink formulations, due to its capability to reduce potential 17 
aggregation phenomena in aqueous solutions, through its stabilizing effect on the biomolecule 18 
structures.[86–88] For instance, the addition of glycerol (generally 10-30 % v/v) to a protein-rich 19 
molecular inks generally permits to obtain high spot definition and resolution.[89] Spots printed 20 
without glycerol showed no regular shape and dimension along with misalignment and 21 
numerous spread small features, due to the formation of satellites during the droplet ejection.[89] 22 
Glycerol helps in raising viscosity in order to increase the stability of the liquid column ejected 23 
from the nozzle finally avoiding the capillary waves that finally lead to droplet multiple 24 
breakups. 25 
2.2 Droplet impact: solid vs. liquid surfaces  26 
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In non-contact techniques, the produced droplets have to be ejected from the orifice where the 1 
formation occurred, in order to be dispensed on the solid substrate. That implies the droplet 2 
impact on the receiving surface. The scenario involved in the droplet impact is quite complex 3 
and will be here briefly described according to the dynamic parameters characterizing the 4 
system, that are dependent on the liquid droplet features along with the physical status of the 5 
receiving surface (solid or liquid).  6 
2.2.1 Impact on solid surfaces 7 
In general, the impact of a micron-sized droplet onto a solid support can be described by a 8 
complex set of events that take into account bouncing, spreading and splashing.[90–92] In the 9 
initial impact phase, the droplet hits the substrate along with air bubbles that can be blocked 10 
inside the droplet at the impact moment. In second phase, there is a rapid radial fluid flow in 11 
which a blob of fluid is formed near the contact line. In the third phase, the fluid comes to rest 12 
in a process of rebound followed by inertial oscillations, damped by viscous dissipation. A high 13 
amount of the initial energy in the droplet before spreading is dissipated by viscosity through 14 
the oscillations. After the fluid has reached its maximum radial extent, oscillations set in after 15 
a rebound in which the droplet remains intact as one volume. By considering an energy balance 16 
based on surface energy, kinetic energy 
𝟏
𝟐
mU2 (m droplet mass, U speed) and the viscous 17 
dissipation when impacting on the solid surface,[92] it is also possible to estimate the size of the 18 
final radius by: 19 
2
3
𝜋𝑅0
3𝜌𝑈2 + 4𝜋𝑅0
2𝜎𝑙𝑣 =  𝜋𝑅𝑓
2(𝑓𝑠𝜎𝑙𝑣 + 𝜎𝑙𝑠 − 𝜎𝑠𝑣) + 𝛥𝐸𝑢                         (6) 20 
 21 
where R0 is the radius of the droplet before impact; Rf  is the final radius after impact has 22 
completed; fs is the ratio of the fluid-vapor surface and the fluid-solid surface; ΔEu is the 23 
dissipated energy in the impact by viscosity; σlv, σls and σsv are the surface energies of the 24 
interfaces between the liquid droplet and the vapor, the liquid droplet and the solid surface and 25 
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the solid surface and the vapor, respectively. The interplay between these factors is reported in 1 
Figure 3D. On this respect, it is important to discuss the role played by the droplet velocity. 2 
When the droplet has low speed (We < 1), the droplet deforms as a whole and flattens somewhat, 3 
already during the first stage of impact - this behavior is explained by considering capillary 4 
force as the important driving mechanism for spreading. In this case, the time scales for 5 
capillary-driven spreading and deformation of the whole droplet are the same. The final radius 6 
becomes larger for experiments with a larger We and is a function of the surface contact angle. 7 
At high droplet velocities, i.e. at high We (> 10), in the first stage of impact the upper part of 8 
the droplet remains undisturbed. The time scale for spreading is significantly smaller than the 9 
time scale for deformation of the droplet by surface tension, permitting the droplet to move 10 
beyond its equilibrium advancing contact angle. 11 
2.2.2 Impact on liquid surfaces 12 
A more complex dynamics occurs for the impact of liquid droplets onto a liquid film; an 13 
excellent dealing with the involved physics is the one of Anderson.[93] An important distinction 14 
has to be made by considering if the printed droplet is miscible or immiscible with the receiving 15 
liquid phase. In the case of miscible phases, the droplet impact strictly depends on its velocity. 16 
At low impact velocities (0.01-1 m/s), no rim is obtained, and the droplet is simply deposited 17 
on the liquid film. At velocities of the order of 1-30 m/s, the motion initiated by the drop is 18 
virtually unconstrained and capable of pushing apart a significant liquid mass under the impact 19 
site. As a result, the droplet takes the shape of a liquid layer with a visible outer rim. At higher 20 
impact velocities (conditions of droplet splashing), the liquid layer takes the shape of crowns 21 
consisting of a thin liquid sheet with an unstable free rim at the top, from which numerous small 22 
secondary droplets are ejected. After the impact, the mixing between the droplet and the liquid 23 
surface occurs. This phenomenology depends upon the molecular diffusion in liquids and then, 24 
assuming a Brownian motion (x2 = 2Dτ, where x is the traveled distance, D is the coefficient of 25 
diffusion, and is τ is the time), it depends on the droplet volume.[94]  26 
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In the case of immiscible phases, which is greatly relevant for Printing Biology applications, 1 
especially in compartments fabrication, the resulting fluid dynamics is definitely more complex, 2 
considering the possible spreading factor effects of the liquid droplet upon the impact liquid 3 
surface. The impact dynamics is governed by the spreading factor S: 4 
S= σliquid surface-vapor − (σliquid ink-vapor + σliquid ink-liquid surface) 5 
In general, this factor is described as the resulting surfaces energy difference between the liquid 6 
surface-vapor (σliquid surface-vapor), and the sum of liquid ink-vapor surface energy (σliquid ink- vapor) 7 
and liquid ink-liquid surface energy (σliquid ink- liquid surface). In the following, two possible 8 
scenarios relevant for Printing Biology will be discussed. The first (reported in Figure 3E) 9 
consists in an aqueous ink impacting on an immiscible and lower density hydrophobic liquid 10 
(ρw > ρo). The second one (reported in Figure 3F) consists in the impact of a hydrophobic ink 11 
droplet on an immiscible lower density aqueous liquid (ρo’ > ρw). In the first case, the spreading 12 
factor can be expressed as S = σov – (σwv  + σow), where σov, σwv, σow represent the oil-vapor, 13 
water-vapor and oil-water surface energies, respectively. This value is typically negative given 14 
the generally low values of σov and the high values of the σwv and σow, resulting in a low 15 
tendency for the droplet to spread. The outcome is the immersion in the case the aqueous droplet 16 
ink has a sufficient velocity ( > 1 m/s) and a higher density with respect to the hydrophobic 17 
phase.[95] 18 
Conversely, the second scenario, expressed as S = σwv – (σo’v  + σo’w), is characterized by a 19 
positive spreading factor, since the σwv is significantly higher than σo’v and σo’w. This results in 20 
a driving force allowing the spread of the hydrophobic droplet on the aqueous droplet (see 21 
Figure 3F). The resulting film can be subjected to further Rayleigh-Plateau instabilities leading 22 
to fragmentation and immersion of smaller oil droplets due to the higher density of the oil 23 
droplet with respect to the aqueous phase.[96] 24 
3. Molecular Building Blocks for Printing Artificial Biosystems 25 
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In the context of Printing Biology, nucleic acids, proteins, phospholipids and carbohydrates 1 
constitute the fundamental blocks to build-up biological modules. In addition to them, water 2 
immiscible molecular systems (hydrophobic oils) and synthetic polymers are useful for 3 
recreating artificial membraneless biosystems or building up artificial systems that can emulate 4 
complex life-like behavior.  5 
3.1 Nucleic Acids 6 
Nucleic acids are the essential biopolymers for the biological systems. They include DNA 7 
(deoxyribonucleic acid) and RNA (ribonucleic acid). The structure of DNA is constituted by 8 
linear polymeric chains of nucleotides (adenine, cytosine, guanine, and thymine). Inside cells, 9 
DNA exist as a pair of strands that are held together by hydrogen bonding between 10 
complementary pairing bases (adenine to thymine and guanine to cytosine), thus forming a 11 
right-handed double helix structure.[97] RNA shows an analogous structure, except for the 12 
presence of uracil instead of thymine and is commonly found as single strand in living systems. 13 
The peculiar features for DNA and RNA reflect the different roles they assumed during the 14 
evolution of biological systems. Whereas DNA has been selected as a for genetic information 15 
storage, RNA is used for transporting the genetic information outside the cell nucleus, in the 16 
form of messenger RNA and to take part to the biochemical pathways involved in the gene 17 
expression. According to some theories about the origin of life, RNA molecules are thought to 18 
both store information for simpler biological systems,[98] and act as a catalyst (for instance the 19 
ribosome is composed primarily of RNA).[99]-[100] 20 
On the printing point of view, DNA is among the most suitable molecular systems for building 21 
up artificial nano- to microstructures featuring complexity and programmability, based upon 22 
the specific Watson–Crick base pairings, leading to the definition of the field of DNA 23 
nanotechnology.[97] This was invented by Nadrian Seeman, as a method to order protein 24 
molecules in a crystalline lattice and later on evolved with the concepts of DNA tiles and the 25 
breakthrough of DNA origami by Rothemund,[101] finally permitting to expand this technology 26 
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to complex nano- to microstructures with tailored geometry, possibility to drive nanodevices 1 
and engineering artificial DNA-based machines (such as bioinspired molecular computing and 2 
robots).[102] Although the initial stages of DNA nanotechnology studies took place in aqueous 3 
solution, current research efforts have started to shift to solid surfaces for direct integration into 4 
devices and biointerfaces. However, the hurdle for applications is the high cost of DNA and the 5 
high error rate of self-assembly. This can be solved by developing large-scale, high-yield, and 6 
scalable synthetic strategies, which can leverage the handling of DNA synthesis by high-7 
throughput processes by liquid dispensing the DNA-based inks. Despite of higher chemical 8 
instability of RNA with respect to DNA, some printing setups have been optimized to deposit 9 
RNA sequences. In particular, by means of microcontact printing, microarrays of RNA have 10 
been obtained by printing RNA oligosequences as polyplexes with polycationic polymers, for 11 
example poly(amidoamide) (PAMAM) dendrimers.[103] A microintaglio printing method for 12 
RNA arraying has been optimized, by exploiting the complementarity of the DNA probes with 13 
the RNA sequences.[104] Finally, more complex structures of RNA, in particular RNA aptamers, 14 
can be deposited on solid supports by inkjet printing, without any loss of functionality.[105] 15 
However, the lower chemical stability of RNA oligonucleotides with respect to DNA, and the 16 
possibility to use equivalent complementary DNA (cDNA) sequences has limited the use of 17 
RNA in printing.  18 
3.2 Proteins 19 
Differently from nucleic acids, proteins are the biomolecules employed in natural systems to 20 
accomplish a plethora of biological functions, such as catalysis, biorecognition, molecular 21 
transport, and other ones. From the structural point of view, proteins are polymers of amino 22 
acids covalently bound through peptide bonds. The peptide chain intramolecular interactions 23 
and the interactions with the water molecules and ions in the surrounding medium induce the 24 
peptide chains rearrangement in the space leading to secondary and tertiary protein structures, 25 
that represent the proper protein folding. Many computational tools can indeed predict the 26 
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protein structure from the amino acid sequence.[106] Interestingly, intrinsically disordered 1 
proteins are able to form mimics of membraneless organelles via liquid-liquid phase separation, 2 
as shown by model studies carried out with elastin-like polypeptides in a microfluidic-based 3 
cytomimetic medium.[107] Artificial protein-based nanostructures can be employed for different 4 
applications ranging from drug delivery, scaffolds, biosensors, etc.[108] Protein-based 5 
nanostructures can be produced by top down approaches involving bacterial protein 6 
microcompartments, engineering these structures to allow labeling of functional molecules and 7 
particles or to tune their geometry. The alternative approaches based on bottom-up fabrication 8 
employs non-covalent[109] or quite recently also covalent[110] protein-protein interactions, to 9 
assemble complex nanostructures which can be used as soft scaffolds for nanomaterials, multi-10 
step enzymatic reactions systems and nanocontainers. Notably, protein molecules are more 11 
prone to degradation, and suffer from mechanical stresses during printing,[111] which make it 12 
more challenging with respect to DNA processing into printed devices. 13 
3.3 Phospholipids and amphiphilic polymers  14 
Phospholipids represent a paradigmatic class of biomolecules usable for building up synthetic 15 
biosystems, since they represent the major component of all the cellular membranes. Generally, 16 
the phospholipids structures consist of two hydrophobic fatty acid tails and one hydrophilic 17 
head, resulting in well-known amphiphilic characteristic, permitting them to form lipid bilayers. 18 
Among them, a remarkable example of phospholipid-based systems is constituted by substrate-19 
supported phospholipid bilayers (SPBs), a versatile model of the biological membrane at the 20 
solid surfaces. One key feature of SPBs is the possibility to generate micropatterned 21 
membranes, allowing for the creation of ordered microarrays that can find applications in drug 22 
screening, studies of molecular interactions and solid-supported biointerfaces under 23 
physicochemical conditions that mimic those of the native biological membrane.[112]  24 
The most common vesicle system in life sciences is based on these biomolecules, namely 25 
liposomes, widely employed as drug carriers, cell membrane model systems and organelle 26 
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mimicking compartments.[113] Liposomes can be prepared by the conventional film-hydration 1 
method, which consists in the deposition of a phospholipid layer, followed by a film hydration 2 
step [114] or by more sophisticated microfluidic approaches.[115] An artificial version of these 3 
systems, defined as polymersomes, is constituted by amphiphilic polymers, which are able to 4 
self-assemble into artificial vesicles enclosing an aqueous cavity.[116] With respect to liposomes, 5 
polymersomes are endowed with higher mechanical resistance and possibility to engineer their 6 
membrane permeability, making them suitable candidates for artificial biosystems.[112] 7 
Additionally, these systems can also be conjugated with biomolecules, as for example proteins, 8 
with straightforward applications in all biological fields.[43] In addition to amphiphilic 9 
polymers, artificial biosystems can also be produced by employing functional polymeric 10 
materials that can be 3D printed to produce smart interfaces with living cells or give rise to 11 
water immiscible systems that can be used as membranelles organelles (see Introduction for 12 
their definition) or synthetic capsules. 13 
3.4 Carbohydrates  14 
The most abundant biomolecules in Nature belong to the carbohydrates category, constituted 15 
by a wide variety of monosaccharides, and their relative oligomers and polymers, obtained by 16 
linking saccharide units through glycosidic bonds. Carbohydrates are ubiquitously found in 17 
living organisms, being involved in several essential processes, such as energy production and 18 
storage, structural functions, as well as extracellular mechanisms of biorecognition.[117] The 19 
intriguing features of carbohydrates have led to a remarkable interest in the use of this class of 20 
biomolecules for printing. Focusing on polysaccharides, they have been used both in 2D and 21 
3D printing processes in order to fabricate solid patterns and scaffolds for cell adhesion. To this 22 
aim, positively charged polysaccharides, e.g. chitosan, have emerged due to the favorable 23 
electrostatic interactions with most of eukaryotic cells, leading to ideal adhesion 24 
platforms.[118,119] 2D inkjet-printed chitosan patterns have also been employed as structural 25 
layer for the fabrication of single-cell arrays.[120] 3D printed chitosan scaffolds have also been 26 
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loaded with bioactive molecules, to develop an artificial printed architecture for cell adhesion 1 
scaffold and surface-mediated drug delivery system.[121] Also, negatively charged 2 
polysaccharides have been exploited as structural matrix for artificial tissue constructs, as 3 
reported for gels of alginate.[122] On the other hand, some strongly hydrophilic non-charged 4 
polysaccharides, e.g. agarose, have been used as biocompatible cell repellent coating, on which 5 
bioadhesive materials can be printed to obtain well-resolved cell patterns.[123,124] Furthermore, 6 
polysaccharides are useful additives for formulation of printable inks for DPN. For instance, 7 
agarose resulted to be a biocompatible carrier matrix for both DNA and proteins, since the 8 
polysaccharide can modulate the inks deposition rates and the transfer of the biomolecules.[125] 9 
Finally, it is noteworthy that very high-molecular weight polysaccharides (> 400 kDa),[126] 10 
could pose some challenges for printing approaches, due to the high viscosity of the resulting 11 
ink. This can be solved by increasing the relative humidity during printing deposition, or by 12 
adding hygroscopic organic additives, e.g. tricine (a glycine derivative).[127]  13 
4. Nanoscale solid-supported Artificial Biosystems 14 
In this section, nanoscale resolution printing methodologies will be investigated, reporting on 15 
their major applications as solid-supported artificial biosystems (see Table 1). The methods 16 
herein described include contact printing methodologies, namely, DPN, PPL and Hard-Tip 17 
Softback Lithography (HSL). Importantly, all the reported methods allow preparing supported 18 
artificial biosystems at variable printing throughput, that can be of interest for the assembling 19 
of functional condensed molecular modules. In particular, by combining high-density 20 
molecular organization and reconfigurable submicrometric spatial organization, such  21 
condensates may be used for single cells manipulation and drug delivery, mimicking the plasma 22 
membrane compartmentalization.[128] 23 
4.1 Nanoscale Printing Methodologies 24 
4.1.1 Dip Pen Nanolithography  25 
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Direct molecular printing approaches at nanoscale resolution have been developed by the 1 
Scanning Probe Lithography (SPL) methods, which use either a sharp single tip, or multiple tip 2 
array, derived from the Atomic Force Microscope (AFM) system to deposit molecular systems 3 
onto solid surfaces, with lateral nanometer scale lateral resolution (i.e. 1–100 nm length scale). 4 
The seminal paper from the group of Mirkin[66] has coined the term DPN for this approach. 5 
DPN permits to directly transfer an extraordinary variety of material “inks” (small molecules, 6 
polymers, DNA, proteins, peptides, colloidal nanoparticles, metal ions, sols, etc.) from microns 7 
down to sub-50 nm length scale.[129–132] DPN allows for direct deposition of molecules from an 8 
ink-loaded tip onto a surface, following a diffusive or a liquid ink mechanism. In the diffusive 9 
case, the ink molecules coated on the tip are deposited through a water meniscus at the interface 10 
between the tip and the surface, leading to the deposition of a monolayer on solid surfaces with 11 
nanoscale lateral resolution.[132] Such process is dependent on molecular diffusion rate and it is 12 
slower for high molecular weight molecules, e.g. proteins or DNA, whose diffusion coefficients 13 
are in the range of 10–12–10–13 m2/s. In the case of liquid inks, ink molecules remain 14 
homogeneously dissolved in the carrier solution. When the ink-loaded pen contacts the surface, 15 
a liquid meniscus is formed. By pulling the tip away from the surface, it is subjected to an 16 
attractive capillary force, which goes to zero at the distance at which the water meniscus breaks, 17 
releasing the droplet.[133] In the liquid ink mechanism, the deposition process depends on the 18 
relative humidity (i.e. the amount of water vapor present in air expressed as a percentage of the 19 
amount needed for saturation at the same temperature), surface tension in between liquid and 20 
tip, liquid and surface as well as on the liquid carrier viscosity. The deposition process is not 21 
dependent upon the molecular weight of the deposited molecule, but mainly on the 22 
physicochemical properties of the liquid carried in which the biomolecule is dissolved.  23 
4.1.2 Polymer Pen Lithography and Hard-Tip Softback Lithography 24 
DPN-based techniques are typically hampered by the inherently low throughput in the 25 
deposition of biomolecules. This technological limitation has been circumvented by replacing 26 
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the conventional cantilevers with a polymeric soft film mounted on rigid substrates, permitting 1 
to obtain a packed array of probes that can be actuated in parallel to deposit biomolecules onto 2 
solid surfaces.[134] The first approach demonstrating this significant evolution is constituted by 3 
PPL.[78,135] It can be defined as a patterning methodology in which pens made of a soft 4 
elastomeric polymer (polydimethylsiloxane) deliver inks[136,137] onto solid supports by 5 
controlling the movement of the pen array with a scanning probe microscope on large areas (on 6 
the order of several cm2) in a single print step.[138] Elastomeric pens are also characterized by 7 
an additional factor for controlling feature size since the pens themselves may deform, resulting 8 
in a force-dependent pen-surface contact area.[139] In particular, as the elastomeric pens are 9 
located in close proximity of the solid support, a diffusive transport mechanism takes place, 10 
mediated by the water meniscus. On the other hand, whether the pens are stamped onto the 11 
support, the mechanism of ink deposition is analogous to Microcontact Printing (see below in 12 
section 5). These mechanisms define extreme cases, then, depending on the elastomeric pens 13 
distance respect to the substrate the ink transfer may follow closer the characteristics of one or 14 
the other.[76]  A further evolution of PPL is constituted by HSL,[68] in which hard silicon tips are 15 
mounted onto polymeric elastomeric backing. This approach is able to combine the high 16 
throughput ability of PPL (large area patterning over cm2) with the high lateral scale resolution 17 
(down to 50 nm), of the DPN-based systems. However, HSL has not found so many bio-related 18 
applications, whereas PPL-based approaches have been widely employed given the higher 19 
simplicity and the remarkable compatibility with different biomolecular systems. 20 
4.2 DNA-based Artificial Biosystems  21 
4.2.1 DPN of DNA-based biosystems 22 
DNA patterning by means of DPN was demonstrated by Demers et al. to generate covalently 23 
bonded patterns of oligonucleotides on gold and SiOx substrates.
[140] The surface of silicon 24 
nitride tips was modified with a chemical compound, i.e. 3-aminopropyltrimethoxysilane, to 25 
promote a good adhesion of DNA ink molecules to the tip surface. Following similar 26 
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approaches, proteins can also be deposited by DPN, as well.[141,142] In this field, our group 1 
described a strategy that employs DPN of oligonucleotide inks dissolved in polyethylene glycol 2 
(PEG) matrixes.[131] Complementary sequences conjugated to a protein of interest were 3 
hybridized to the spotted DNA sequence via DNA directed immobilization (DDI).[143] Optimal 4 
deposition parameters consisted in PEG 1000 molecular weight, relative humidity as high as 5 
30%, and a capture oligonucleotide concentration of 100 μM. Oligonucleotides complementary 6 
to the immobilized capture sequences were covalently linked to streptavidin, and the resulting 7 
conjugates were functionalized with fluorolabelled biotinylated antibodies. The streptavidin–8 
antibody complexes were bound to the immobilized capture-oligonucleotide arrays, resulting 9 
in a protein array, suitable for functionalization with the epidermal growth factor to recruit the 10 
complementary membrane receptor (EGFR) in the plasma membrane of MCF7 cells (Figure 4 11 
A-B). The combination of DPN with DDI was used for the fabrication of arrays containing two 12 
capture oligonucleotides, resulting in two different protein patterns.[130] The multiplexed 13 
microarray was applied to simultaneously measure the interaction of two bait-presenting 14 
artificial receptor constructs (PARCs) - i.e. the regulatory domain RII-b and the regulatory 15 
domain RI-a of protein kinase A (PKA) - with a prey protein construct constituted by the 16 
catalytic subunit mCherry-cat-α of PKA fused to the fluorescent protein mCherry inside single 17 
living cells. The two different PARCs were attached to the surface since in their extracellular 18 
region, they showed two different epitopes, respectively VSV-G bait and HA bait that are 19 
selectively captured by respective biotinylated antibodies linked to the ssDNA–streptavidin 20 
conjugate which is hybridized to the complementary ssDNA deposited by DPN. In Figure 4C, 21 
a single cell recruited on an anti-VSVG functionalized surface is shown. [130]  22 
4.2.2 PPL of DNA-based biosystems 23 
To improve the efficiency of multiplexed surface patterning in Printing Biology, Arrabito and 24 
collaborators developed a prototype of a robust custom plotter based on PPL, allowing rapid 25 
fabrication of microarrays at ambient conditions.[78] Subsequent to optimization of ink viscosity 26 
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and surface tension by glycerol and polyoxyethylene (20) sorbitan monolaurate (respectively at 1 
concentrations equal to 5% v/v and 0.1% v/v) addition, DNA arrays were plotted and used for 2 
DDI of EGF-bearing ssDNA–streptavidin conjugates. MCF7 cells expressing EGFP–EGFR 3 
were cultured on those functionalized surfaces. The microarrays showed the ability to recruit 4 
and activate EGF receptors in sub-cellular regions within human MCF7 cells, which were 5 
stained with antibodies against active EGFR, which is phosphorylated at tyrosine 1068. The 6 
ratio between phosphorylated and total EGFR permitted to measure the activation state of this 7 
receptor, finding that a significantly higher fraction of EGF receptors was phosphorylated 8 
within cell regions that contacted EGF functionalized surfaces (see Figure 4D). In a recent 9 
paper, Angelin and coworkers[144] demonstrated the site-directed sorting of protein-decorated 10 
DNA origami structures on DNA microarrays. The combination of bottom-up self-assembly of 11 
protein–DNA nanostructures and PPL allowed the realization of multiscale origami structures 12 
as biointerface, deriving from the 5438 nucleotides template 109Z5 having nine single-stranded 13 
DNA (ssDNA) binding tags, protruding from one side of the plane of the quasi-2D 14 
nanostructure. The nine binding sites were bound to their complementary surface-bound capture 15 
oligonucleotides. This technology permitted to investigate the activation of EGF receptors in 16 
living MCF7 cells through distinctive nanoscale arrangements of EGF ligands. Such approach 17 
led to the assembly of structures having the same size of biomolecular assemblies present in the 18 
membrane of living cells, that are composed of tens to thousands of molecules (sizes around 5–19 
100 nm) and that play a crucial role in the outcome of signaling events. 20 
4.3 Phospholipids-based artificial biosystems 21 
4.3.1 DPN of phospholipid-based inks 22 
In the context of Printing Biology by DPN, a high relevant class of biomolecules is certainly 23 
represented by phospholipids, resulting in the L-DPN acronym to refer to lipid patterning via 24 
DPN.[129] The importance of phospholipids patterning is related to their fundamental roles in 25 
biology as main components of cell and subcellular organelle membranes, as well as signaling 26 
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molecules. Remarkably, the phospholipid inks exhibit peculiar properties with respect to the 1 
diffusive and liquid ones. In particular, phospholipid molecules loaded on the DPN tip undergo 2 
a humidity-dependent hydration process to be released onto the substrate. When properly 3 
hydrated, phospholipids diffuse from the tip towards the support through the water meniscus, 4 
like in a diffusive ink.[76] However, it has also been demonstrated that the ink flow can be 5 
modified by controlling the relative humidity, and the deposited spots are domed-shaped, both 6 
characteristics of liquid inks.[145] Therefore, phospholipid inks feature a combination of both 7 
diffusive and liquid inks properties, offering the possibility to involve an alternative rheology 8 
in molecular printing. Another important aspect is the chemical structure of the phospholipid 9 
molecules, especially regarding the hydrophobic chains, whose chemical composition strongly 10 
affects the chain-ordered phase transition temperature. To achieve a proper direct-writing 11 
process, the temperature during printing has to be maintained above the transition temperature 12 
in order to keep a suitable ink fluidity.[76] Noteworthy, the L-DPN can also been performed in 13 
aqueous solution taking advantage of the lipid patterns insolubility and stability in water.[146] 14 
As deposited by DPN, they can form multiple stacks of hydrated bilayers,[147] that have opened 15 
up different applications. For instance, when employed as biointerfaces, phospholipid patterns 16 
can interact with cell membrane and induce the delivery of small molecule from the support 17 
into adherent cells.[148,149] The fabrication of phospholipid-based surface-mediated delivery 18 
systems has been demonstrated by Kusi-Appiah et al.,[148] (see Figure 5A) that have shown the 19 
internalization of both valinomycin and docetaxel drugs by adherent cells. Interestingly, the 20 
bioactive molecules transferred from the subcellular phospholipid printed spots into the cells in 21 
a multilayer thickness-dependent fashion, with no cross-contamination between different 22 
functionalized areas.  23 
In addition, phospholipids are traditionally assembled on solid supports to obtain SPBs to be 24 
employed as biological membrane models,[150] whose thickness (2 to 100 nm) and lateral 25 
resolution, as well as geometry and shape, can be finely controlled and modulated by DPN.[151] 26 
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Such artificial membranes with high controlled dimensional features have found remarkable 1 
applications as optical biosensors as well. In fact, exploiting the high control on the spot height 2 
attainable by DPN, Lenhert and coworkers fabricated lipid multilayer gratings, whose response 3 
in terms of light diffraction changes upon phospholipid layers rearrangements, as well as after 4 
interaction with proteins intercalated in the multilayer structure, resulting in a label-free optical 5 
detection platform for lipid binding biomolecules.[152]  6 
4.3.2 PPL of phospholipid-based inks 7 
PLL has also been utilized to obtain phospholipid patterns as well, exploiting the high-8 
throughput capability and multiplexing potentiality of a multi-probe system.[129] As 9 
aforementioned, phospholipid deposition from a DPN tip occurs as a combination of diffusive 10 
and liquid ink transport mechanisms.[76] This phospholipid ink deposition by PPL has been 11 
systematically investigated by Angelin and collaborators, (see Figure 5B) demonstrating a 12 
minor effect of dwell time and printing pressure in phospholipid PPL respect to other diffusive 13 
inks.[136] In the same work, the authors demonstrated the application of the phospholipid 14 
patterns by PPL as cell recruitments platforms through an extracellular receptor binding 15 
mechanism at the printed surface. The principle has been demonstrated dispensing 1,2-16 
dipalmitoyl-sn-glycero-3-phosphoethanolamine bearing the model allergen dinitrophenol in an 17 
array fashion on a glass support. Mast cells RBL 2H3, sensitized with the fluorolabelled anti-18 
dinitrophenol IgE, have shown a co-localization of the cell bound antibody with the 19 
allergen/lipid pattern.[136] Moreover, PPL can be leveraged for an accurate biomolecular 20 
gradient fabrication by finely tuning the printing pressure, and consequently the relative 21 
distance between tips and substrate.[135] To this aim, elastomeric pens holder has been tilted 22 
respect to the solid substrate, resulting in a gradient of printing pressure along the different tip 23 
lines. This procedure permitted to obtain in a single printing run different multi-stacking 24 
bilayers of phospholipids, whose height depends on the applied pressure.  25 
 26 
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5. Microscale and Macroscale Artificial Biosystems: from artificial compartments to 1 
synthetic tissues and bioinspired electronic networks 2 
In this section, the relevant methodologies of microscale printing and their main applications in 3 
developing artificial biosystems will be reported. The methods herein described include µCP, 4 
Inkjet Printing (IJP) and 3D Printing (see Table 2 and Table 3). Differently from the previously 5 
reported nanoscale biosystems, the herein described microscale artificial biosystems have been 6 
assembled not only at solid surfaces but also into liquids, allowing obtaining a larger variety of 7 
artificial compartments and complex life-like assemblies at solid surfaces and into 8 
reconfigurable liquids environments. This section reports examples of further organization of 9 
the resulting artificial compartments to form complex 3D assemblies which are responsive to 10 
external triggers (such as light, osmolarity, electrical currents), finally leading to artificial 11 
tissues, scaffolds, organs and life-inspired electronics devices based on printed artificial 12 
neuronal networks. ⁠ 13 
5.1 Microscale Printing Methodologies 14 
5.1.1 Microcontact Printing 15 
The μCP method is among the most common patterning approaches for the deposition of 16 
organic molecules and biomolecules on large areas (> cm2) and was developed by Kumar and 17 
Whitesides.[153]  Differently from other approaches, μCP is featured with simplicity, low cost, 18 
compatibility with different types of liquids, becoming a routine method to generate patterns at 19 
the microscale.[154] The μCP method uses an elastomeric mold, realized from a negative master 20 
mold, on which a liquid prepolymer is poured. Once the polymerization is completed by a 21 
curing step, the mold is separated from the master and ready for use. Then, it is dipped in the 22 
solution containing the molecules to be deposited on the surface. After an incubation time 23 
(typically some minutes), it is dried and pressed on the substrate in order to favor the molecules 24 
transferring to the surface. Polydimethylsiloxane (PDMS) is the material of choice for μCP, 25 
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because of its low-cost and suitability for conventional laboratories. Similarly to Scanning 1 
Probe Lithography approaches, μCP allows for deposition of biomolecules onto solid supports 2 
and has found many applications in the field of molecular dispensing on solid surfaces which 3 
have recently been developed.  4 
5.1.2 Inkjet Printing  5 
The Inkjet Printing (IJP) method is among the most convenient printing approaches, allowing 6 
for the fabrication of wide variety of molecular arrays.[155,156] Generally, the inkjetted droplets 7 
are in the volume range of 10-1-102 pL and are dispensed through a mechanism based on the 8 
generation of a pressure pulse within the ink, causing the droplet ejection from a micrometric 9 
orifice, often referred as nozzle.[5] The IJP technology has been implemented in many different 10 
forms that can be categorized into the Continuous Inkjet Printing (CIJ) and the Drop-on-11 
Demand Inkjet (DOD) printing methods. In the case of CIJ, the ink is subjected to a high 12 
pressure through the nozzle resulting in a jet that breaks up into a stream of droplets through 13 
the Rayleigh instability.[89] In the DOD approach, the droplets are generated by the actuation of 14 
series of pressure pulses inducing the droplet formation in a controlled manner.[157] The DOD 15 
approaches can be divided according to drop formation mechanism into thermal, piezoelectric, 16 
electrostatic, and acoustic, electrohydrodynamic and valve methods.[158] The piezoelectric-17 
based technology is currently the most commonly employed. In this case, the system employs 18 
a high-pressure pump with a piezoelectric crystal, such as lead zirconate titanate, that works as 19 
actuator to dispense droplets by a series of electrical pulses that induce shear and compression 20 
stresses on the liquid. Note that the structure of the most fragile biomolecules can be affected 21 
by the printing process as the droplets experience relative high shear stresses while flowing 22 
through the nozzle and impacting the substrate surface.[159] 23 
The ink rheological properties play a fundamental role for the printing process. A convenient 24 
approach to illustrate the different regimes of inkjet printing is the Derby plot which reports the 25 
We number against the Re number, permitting to individuate regions which are compatible with 26 
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jettable fluids or with satellites production.[160] In order to obtain sufficient ballistic accuracy of 1 
a droplet, the We number should be higher than 1. The Re number should be higher than 1 as 2 
well, in order to prevent excessive viscous damping, while the need for some damping of the 3 
fluid after droplet generation puts an upper bound on its value.[92]  4 
5.1.3 3D printing 5 
Additive manufacturing technologies, commonly referred as three-dimensional (3D) printing, 6 
have emerged over the last years as a promising approach for the creation of customizable 7 
fabrication paradigms for life sciences. Differently to the previously discussed printing 8 
techniques, mainly involved in the fabrication of 2D artificial biosystems, the 3D printing 9 
approaches offer the possibility to build up 3D complex architectures mimicking the properties 10 
and structures of the biological systems, reaching the macro-scale. There are some recent 11 
reviews detailing the plethora of reported 3D printing techniques.[161,162] This technology 12 
permits to draw reconfigurable objects by means of computer-aided design (CAD) software, 13 
offering the possibility to optimize the design and the 3D structure in a sequence of layers. 3D 14 
printing eliminates the photolithographic step and obviates the need for expensive silicon-15 
processing infrastructure.  16 
The earliest form of 3D printing is Stereolithography (SL),[163] based on the employment of a 17 
liquid photoresin, which undergoes photopolymerization under UV-light irradiation. The 18 
process goes on layer-by layer, until the structure is complete, following a draining of the 19 
unreacted resin and a final irradiation with stroboscopic UV-light in order to cross-link 20 
available sites, improve mechanical properties and uniform hardness. The possibility to 21 
recollect unreacted resin, to use limited amount of material and high resolution control given 22 
by light source resolution (in the range of micrometer to nanometer scale)[164] makes it the 23 
protocol of choice for several researchers. Typical materials applied for SL comprise 24 
acrylates,[165,166] hydroxyapatite combined with polymer matrices,[167] poly(propylene 25 
fumarate)s,[168] polycaprolactones,[169] and poly(D,L-lactide) resins.
[170] Recently, the library has 26 
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been expanded by silicon‐oxycarbide chemistry, which successfully ended up in the preparation 1 
of 3D ceramic structures.[171] Projection-based protocols are one of the most recent evolution 2 
of SL protocols, allowing the definition of extremely sharp, fractal-like patterns, in closely 3 
similar to natural circulatory systems of living beings.[172,173] Another interesting surprise comes 4 
from spider-inspired 3D printing technique,[174] an extrusion-based 3D printing method with a 5 
multi-barrel nozzle where the crucial role is played by the parallel printing of multiple 6 
components, forming a stable and biocompatible network after UV-initiated gelation of sodium 7 
alginate and acrylamide.  8 
The achievements obtained through the 3D printing techniques represent a cornerstone for 9 
researchers targeting the understanding of basic mechanisms of life at cell-scale, and the 10 
fabrication of complex artificial biological apparatuses.[175] The realization of hollow tubular 11 
structures drives further investigations aiming at merging 3D printing with microfluidic 12 
circuits, disclosing the possibility to create 3D biological fluidic environments for advanced 13 
cell cultivation, with features closely resembling natural architectures.[176] Microfluidic 14 
apparatuses realization by means of 3D printing necessarily calls for a wide-range investigation 15 
of new formulations and bioinks (a mixture of cells, biomaterials and bioactive molecules) 16 
allowing realizing biomimetic constructs. Bioinks formulations were limited in the early days 17 
of 3D printing, and this condition forced scientists to put several efforts in their investigation, 18 
culminating in the plethora of viable options that are described up to date.[177] Among the 19 
highest achievements, an important goal has been the production of bioinks compatible with 20 
many cell phenotypes, ending up in the realization of functional 3D-printed biofilms and living 21 
biofilm-derived materials. ⁠[178] For an overview of the latest formulations and the recent trends, 22 
the review work given by Donderwinkel and co-workers is warmly recommended. ⁠[179] 23 
 24 
5.2 Liquid Microscale Bio-Compartments Printed at Solid Surfaces 25 
  
29 
 
5.2.1 DNA-rich microcompartments  1 
Nyamjav and Holz demonstrated the use of μCP as a robust, reliable and inexpensive method 2 
to produce high-density microarrays of DNA molecules directly on silicon oxide substrates. 3 
The coupling of oligonucleotides to a silicon substrate was achieved by silanization of an 4 
acrylamide-terminated DNA, resulting in arrayed oligonucleotides with retained biological 5 
function.[180] The μCP method was also used for the immobilization of lipidic vesicles 6 
containing amphiphilic β-cyclodextrin interconnected by biotin−streptavidin linker 7 
molecules.[181] A very intriguing example of μCP versatility was provided by the group of prof. 8 
He,[182] who demonstrated the fabrication of self-propelled chitosan/alginate polyelectrolyte 9 
multilayer (PEM) microsized films onto poly(vinylalcohol) (PVA) coated glass slides (Figure 10 
6 A-C). These PEM systems have a spontaneous rolling behavior and ultimately give rise to 11 
microrockets when in presence of platinum nanoparticles, which can catalyze the 12 
decomposition of H2O2 into water and gaseous oxygen. The resulting microrockets can travel 13 
around straight trajectories, reaching speed of more than 50 μm/s.[182]  14 
The IJP method has been leveraged as a robust approach for the study of molecular interaction 15 
onto 2D solid-supports, following the application of protein microarray platforms.[183] DNA 16 
molecules are fully compatible with IJP[184] allowing for the realization of microarrays usable 17 
as gene or cDNA probes. The IJP methodology can be a fundamental tool allowing printing 18 
chip-derived staple strands to assemble large DNA origami at low cost on 2D chips. The staple 19 
strands were individually synthesized on pillars and amplified off the chip surface by nicking-20 
strand displacement amplification. The oligonucleotides were amplified via PCR and released 21 
as single stranded DNA to be used for folding a 51-kilobasepair origami from the λ/M13 hybrid 22 
scaffold.[185] Similarly, 3D printing has been shown as suitable approach for assembling DNA 23 
molecules for molecular cloning, following the Golden Gate DNA assembly in 3D inkjet-24 
printed fluidics.[186]  25 
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Differently, proteins inkjet printing can be a more challenging task due to the possible 1 
mechanical stresses that can compromise their structure during droplet formation and 2 
impact.[159] These issues can be solved by tuning the deposition process, obtaining a droplet 3 
velocity enough for good directionality (i.e. around 5-6 m/s) without imposing excessive shear 4 
and compression stresses. In particular, our group[69] produced an all-printed 2D drug screening 5 
platform in which pL-scale volume droplets containing a model enzymatic substrate/inhibitor 6 
couple (D-glucose or a mixture of D-glucose/D-glucal) were inkjet-printed onto a glucose 7 
oxidase monolayer immobilized on silicon oxide. Upon hitting the solid surface, the droplets 8 
formed rounded spots with diameters of about 40-50 µm. Figure 5D reports optical images of 9 
alternated D-glucose rich (absence of D-glucal) and D-glucose/D-glucal (D-glucal molar 10 
fraction equal to 0.88) rich spotted lines, as freshly printed and after 90 minutes of incubation 11 
are shown, respectively. A colorimetric detection based on the horseradish peroxidase 12 
method[159] allowed to probe the interaction between the dispensed molecules and the enzymatic 13 
target at the single spot in such 2D chip (Figure 6 D-E). 14 
5.2.2 Protein-rich microcompartments  15 
Protein immobilization by chemisorption on a solid surface is not mimicking the biological 16 
conditions, since the strong bond between the macromolecules and the solid support affects the 17 
structure and the biological activity of the biomolecules. A non-covalent printing approach 18 
compatible with solid surfaces would be highly desired. In this regard, Mugherli et al. leveraged 19 
surface‐tension nL-scale 2D droplets microarrays stabilized within DMSO/glycerol (9:1) 20 
droplets, to investigate derivatives of phenylboronic acid and their profiling against the NS3/4A 21 
protease of the hepatitis C virus.[187] A further innovation was demonstrated by our group[188] 22 
in the form of a 3D layer-by-layer fabrication of the enzymatic array in which ink droplets 23 
remained stable both during the multilayer-assembling and the execution of the assay thanks to 24 
the high hygroscopicity of glycerol added to the ink at 30% v/v, to maintain a constant water 25 
content in the printed droplets.[189] The resulting CYP3A4-catalyzed reactions were conducted 26 
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in such pL-scale spots, and the enzymatic inhibition was verified at the single spot level by 1 
luminometric detection. Notwithstanding the advantages of such non-covalent printing 2 
approach, glycerol significantly affected the enzymatic kinetics. As an alternative to glycerol-3 
based inks, Mateen et al. developed printing approaches, based on a drop-on-demand syringe 4 
solenoid printer. They used hydrogel inks onto nitrocellulose, protecting the biomolecules 5 
against drying and denaturation.[190] By using β-lac as a model protein, the enzyme-6 
immobilizing hydrogel can be employed for drug screening applications. Recently, Benz and 7 
collaborators demonstrated that combinatorial synthesis and cellular screening can be applied 8 
within biochips printed by a non-contact liquid dispenser,[191] permitting the combination of 9 
chemical synthesis with in vivo screening by recreating biologically native conditions in at the 10 
µL-scale droplets.  11 
5.2.3 Phospholipids-rich microcompartments  12 
A further step towards evolved artificial biosystems printing is constituted by the possibility to 13 
define lipid vesicles that perform operations similar to those of cellular systems or smart bio-14 
inspired machines usable for drug delivery, artificial organelles or bioreactors. 15 
IJP allows for the realization of a 2D microarray of model biological membranes on solid 16 
substrates.[192] Lipids were inkjet-printed onto a glass substrate that was functionalized with 17 
microsized membranes of phospholipid bilayers which were in turn realized by the lithographic 18 
photopolymerization of a diacetylene-containing phospholipid, 1,2-bis(10,12-tricosadiynoyl)-19 
sn-glycero-3-phosphocholine (DiynePC). IJP permitted the direct incorporation of the natural 20 
lipid membranes into the polymer-free regions (corrals). Notably, an aqueous solution 21 
containing agarose and trehalose was printed onto the corrals beforehand to stabilize the 22 
phospholipids bilayers and subsequently printed lipid suspensions. Fluorescence recovery after 23 
photobleaching (FRAP) measurements confirmed the fluidity of the phospholipids structures 24 
(Figure 6F-G). After removal of non-polymerized DiynePC with a detergent solution, the lipid 25 
membranes were incorporated within the corrals, by using an electric-field- based IJP that can 26 
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eject sub fL-volume droplets. To avoid rapid dehydration and destabilization, an aqueous 1 
solution containing agarose and trehalose and subsequently lipid suspensions were printed onto 2 
the corrals. After rinsing, stable lipid bilayer membranes were formed in the corrals. Lalone et 3 
al. demonstrated the possibility to engineer single-cell-sized 2D micro-calibration standards by 4 
IJP ink formulations containing high-density lipoprotein nanodiscs (HDLs) to dissolve 5 
phospholipid in aqueous ink formulations. The inks were printed by a piezoelectric actuated 6 
inkjet printer onto silicon surfaces and single cells adhered to them, allowing for quantitative 7 
phenotypic characterization of cell populations on the basis of absolute biomolecular 8 
composition, specifically measuring the total amounts of protein, lipid, nucleic acid and 9 
carbohydrate present inside them.[193]  10 
5.3 Aqueous compartments into liquids 11 
5.3.1 Printing protein-rich aqueous liquid microcompartments  12 
A further step towards native conditions is printing aqueous compartments that mimic the 13 
composition of cellular systems. This can be achieved by printing inks in the form of pL-scale 14 
aqueous droplets into mineral oil drops.[194] The oil drop has a high boiling temperature, then is 15 
able to completely protects the printed aqueous droplets against fast evaporation. However, the 16 
molecular content inside the aqueous droplet is subjected to leakage into the oil phase. In this 17 
regard, the water/oil interface needs to be stabilized by non-ionic mild surfactants 18 
(polyoxyethylene 20 sorbitan monolaurate). The resulting aqueous environments constitute 19 
artificial compartments in which few molecular interactions can be quantitatively investigated. 20 
For example, the biotin/streptavidin model interaction has been investigated by Raster Image 21 
Correlation Spectroscopy (RICS), an advanced fluorescence technique enabling to follow 22 
molecular dynamic processes, in conditions similar to those of aqueous confined compartments 23 
(Figure 7 A-B).[95]  24 
A transition to a crucially different molecular behavior is observed by downscaling the size of 25 
the printed droplet at fL scale, which actually corresponds to the size of subcellular 26 
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organelles.[31,33] Differently from previously developed set-ups such as satellites printing or 1 
droplet generation in liquid environments[82,83] which have not been demonstrated to be suitable 2 
for biomolecular systems, our group has recently designed a printing approach based on 3 
piezoelectric IJP for the fabrication of artificial compartments at fL scale.[85] In particular, by 4 
following the theoretical model from Eggers and coworkers,[195] in which the droplet size can 5 
be finely tuned by minimizing the actuation time of the transducer, we were able to produce 6 
stable fL-scale droplets, containing a mixture of non-ionic surfactants - the di-block copolymer 7 
poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) (PEG-PPG-8 
PEG) (0.03% w/v), and polyoxyethylene (20) sorbitan monolaurate (0.05% v/v). The droplets 9 
were printed into nL-scale oil drops, and the resulting water/oil interface was stabilized by the 10 
non-ionic surfactants. Note that the fL-droplets form an almost-regular circular pattern at the 11 
border of mineral oil drops due to Marangoni flows (see Figure 7C). In turn, the downscaling 12 
at the fL-size triggered the formation of molecularly crowded shells at the water/oil interface, 13 
with a typical thickness in the order of hundreds of nanometers, in accordance with models.[196]  14 
This approach has been exploited to study two different biomolecular systems: first, a DNA 15 
hairpin in presence of a molecular triggers (i.e. a complementary sequence which leads to the 16 
formation of the double helix sequence), and second a CYP2E1-catalyzed enzymatic reaction 17 
in which 7‐(ethoxymethoxy)‐2‐oxo‐2H‐1‐benzopyran‐3‐carbonitrile (EOMCC) is converted to 18 
the fluorescent molecule 3-Cyano-7-hydroxycoumarin (CHC) (see Figure 7D). More 19 
specifically, molecular crowding effects were tested by using Fluorescence Lifetime Imaging 20 
Microscopy (FLIM), revealing different characteristic fluorescence lifetimes of environmental 21 
sensitive specific probes in the confined volumes with respect to bulk solutions, due to water 22 
molecules depletion effects.[197]  23 
5.3.2 Phospholipids-rich aqueous liquid microcompartments  24 
A completely different scenario occurs when phospholipid inks are printed into aqueous phases. 25 
The pioneer investigations (not by printing methods) from Elani and collaborators leveraging 26 
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macroscale droplets produced by manual[198] and microfluidic[199] droplet formation, defined 1 
the possibility to produce compartmentalized vesicles by transferring a set number of lipid-2 
coated water-in-oil nL-scale droplets from an oil to an aqueous solution (phase transfer). The 3 
droplets were used to compartmentalize biochemical reactions, and for engineered signaling 4 
cascade within an artificial cellular system.[198,199] As far as IJP is concerned, Hauschild et 5 
al.[200] prepared inks from phosphatidylcholines and two block copolymers, poly(2-6 
vinylpyridine)-block-poly(ethyleneglycol) of different block lengths. In their experiments, they 7 
used commercial piezoelectric inkjet printers to print pL-scale droplets containing a solution of 8 
a vesicle‐forming amphiphile into an aqueous solution, where the amphiphiles are able to 9 
assemble into vesicles. They observed that inks with a solution of the vesicle-forming 10 
amphiphile (0.1–5 wt.%) in ethanol gave rise to unilamellar vesicles in the 50-200 nm size 11 
ranges when printed in the aqueous solution. This result might appear unexpected since the 12 
droplet size is in the order of microns, but can be explained due to the fact that the vesicle 13 
formation proceeds via a nucleation and growth process. The author argued that the well-14 
controlled distribution of monodisperse droplets by the printhead leads to a stable level of 15 
supersaturation, permitting a fine control of the number of nuclei and the resulting vesicle 16 
size.[200] IJP has been also involved in the manufacturing of more complex phospholipid 17 
particles in order to build up cell-mimicking compartments, whose properties can be finely 18 
tuned through the printing process. In particular, Stachowiak and coworkers[201] have reported 19 
an elegant piezoelectric inkjet setup, which allows to simultaneously form and load unilamellar 20 
liposomes by directly injecting droplets of cargo-containing ink at the phospholipid solution 21 
interface. By tuning the printing parameters, such as pulse number and pulse voltage, as well 22 
as ink viscosity by biocompatible additives, they demonstrated the possibility to assembly 23 
particles with diameters ranging from 10 to 400 µm, as well as the encapsulation of the actin, 24 
which is a fundamental constituent of the cell cytoskeleton, and the study of its intravesicle 25 
polymerization. The resulting colloid exhibits the essential structural characteristics of a cell 26 
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(membrane and protein-based internal architecture), and promising features as artificial cell 1 
(Figure 7E-F).  2 
 3 
5.3.3 Printing compartments networks: towards artificial tissues 4 
3D printing approaches have been applied for the fabrication of tissue-like biological 5 
architectures, allowing mimicking cellular networks. In a remarkable example from the group 6 
of Bayley,[202] tens of thousands of pL-scale aqueous droplets were printed by a drop on demand 7 
by piezoelectric actuated 3D printer to become joined by single lipid bilayers, leading to a 8 
patterned, cohesive, tissue-like materials made up of cooperating artificial compartments. The 9 
staphylococcal 𝛼 -hemolysin ( 𝛼 HL) protein was added to the phospholipids to create an 10 
ionically conductive droplet network (Figure 8A). The droplets pattern can be folded by the 11 
presence of osmosis triggers. The different osmolarity between adjacent droplets determine 12 
flow of water through the bilayer causing the droplets to swell or shrink (Figure 8B).  13 
This printing approach has been proposed also as a powerful technology to be applied for self-14 
assembling biomolecular memristors as synaptic mimics,[203] where deposition has been 15 
performed following DOD approach governed by piezoelectric actuation. The same 16 
piezoelectric actuated 3D printing method can be applied for the realization of synthetic tissues 17 
that, under a light activated DNA promoter system, permit the expression of a model protein 18 
(the mVenus protein) inside the synthetic cells (Figure 8C-D).[204] After light activation, optical 19 
investigation of the set of the artificial cells permits to visualize the cells where the yellow 20 
mVenus protein is expressed (Figure 8E). 21 
3D printing also allows the assembly of water-in-water constructs. This process is challenging, 22 
due to the lack of a strong thermodynamic driving force, pivoting the phase separation 23 
phenomena. Nevertheless, some interesting reports describe how this goal can be achieved by 24 
synthesizing a membrane able to separate the inner space of the micro-constructs from the outer 25 
environment. Literature reports hollow tubular architectures, ⁠[205] where separation is achieved 26 
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by means of a combination of dextran and PEG solutions. Those tubules demonstrated to induce 1 
selective ion separation and accumulation, and selectively sequester, accumulate, and transfer 2 
charged molecules. Similarly, globular capsules can be designed as 3D reactors for cell 3 
culture.[206] ⁠Here, sodium alginate sodium dodecyl sulphate were the main constituents of the 4 
membrane layer, while the core space is constituted by an aqueous solution of hydroxy-ethyl 5 
cellulose. 6 
3D printing approaches have also been applied for the fabrication of organ-like constructs, a 7 
cutting-edge aspect for the development of innovative tools in modern tissue engineering and 8 
surgery practice.[207–209] For instance, a new 3D printing approach, termed Freeform Reversible 9 
Embedding of Suspended Hydrogels (FRESH),[210] has shown great potentiality in the 10 
fabrication of a plethora of artificial organs, thus representing a general purpose tool for 11 
prosthesis architectures production. In particular, this strategy relies on the deposition of 12 
biomaterial, such as alginate, collagen, and fibrin, containing ink into a sacrificial thermo-13 
responsive hydrogel of gelatin, which guarantees that the first fluid ink not to collapse. Once 14 
the biomaterial has gained the sufficient mechanical stability, the sacrificial hydrogel limits can 15 
be dissolved by simple heating a 37 °C. The FRESH methodology has been further exploited 16 
to fabricate several proof-of-concept structures, such as artificial bones, branched coronary 17 
arteries, embryonic and neonatal-scale human hearts.[210,211] 3D Printing approaches can be 18 
leveraged even to generate an artificial electric organ, as demonstrated by Schroeder and 19 
coworkers[212] who reproduced the functionality of the electric organ of the knife fish 20 
Electrophorus electricus (the electric eel). The authors printed thousands of compartmentalized 21 
polyacrylamide hydrogel compartments by a 3D bioprinter bounded by a repeating sequence of 22 
cation- and anion- selective hydrogel membranes, in order that the resulting materials generated 23 
total open-circuit potential differences in excess of 100 V and power densities of 27 mW/m2.  24 
 25 
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5.4 Towards autonomy: from primitive life-like entities towards artificial organs and 1 
neuromorphic systems 2 
Self-propelling liquid compartments and autonomous vesicles can also be employed for 3 
building artificial systems that can find relevant technological applications, ranging from 4 
molecular encapsulation, stimuli-triggered devices, scaffolds, artificial tissues, neural networks 5 
and synapis-inspired computers towards living organisms. 6 
5.4.1 Primitive autonomous objects 7 
Liquid-liquid phase separation is an emerging topic, being clear the central role it assumes for 8 
the formation of autonomous biomolecular condensates or membranelless compartments within 9 
cellular environments.[33,51] The research on this field is still at its infancy[213] and many efforts 10 
are needed in order to properly understand the role of such condensates, acting as biological 11 
compartments and bioreactors, filters, and membranelless organelles in cells. This has 12 
motivated many researches to deeply understand the underlying physical principles and the 13 
specific properties of these systems to bring insights into a wide range of biological processes 14 
for healthy cells and their roles in contexts ranging from development to age-related diseases, 15 
finally providing some technologically relevant applications as bioreactors or liquid individual 16 
capsules for drug/molecular encapsulation in immiscible liquids.[214] 17 
In principle, phase separation can trigger the formation of primitive autonomous objects, which 18 
can freely move within a continuous liquid phase. A model of liquid-liquid phase separation is 19 
constituted by the oil-in-water droplets emulsions, that can be used as primitive life-like systems 20 
given their ability to move in aqueous media in presence of chemical triggers (surfactant 21 
concentration gradient, solid-liquid interfacial tension and other ones).[36–38] In this regard, IJP 22 
represents an ideal approach for producing oil droplets on demand, as firstly demonstrated by 23 
Zeng and collaborators[215] who inkjet printed oil droplets at sizes comprised in the hundreds of 24 
microns (210–290 μm). Their inkjet nozzles were immersed in the water phase, and the size of 25 
the droplets was tuned by varying the applied voltage and the pulse width exerted on the piezo 26 
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actuator. Our group has recently demonstrated the possibility to produce fL-scale oil-in-water 1 
droplets by piezoelectric IJP after spontaneous interfacial droplet fragmentation.[216] In 2 
particular, pL-scale fluorinated oil drops were printed onto a surfactant-laden water surface at 3 
moderately high We number (~ 101), then they spread, and fragment at the water/air interface. 4 
The fragmentation at the interface is due to capillary instabilities, which lead to oil pL-drops 5 
rupture into fL-droplets in accordance to the reported models for systems at macroscale (Figure 6 
9A).[96] A low concentration (0.003% v/v) of the biocompatible polyoxyethylene (80) sorbitan 7 
monooleate surfactant (Tween 80) was added the receiving aqueous phase to lower the surface 8 
tension. As a result, the fL-droplets are observed only if the surfactant concentration was equal 9 
or higher than its critical micellar concentration, which corresponds to a complete saturation of 10 
the interface with the surfactant molecules. This is a crucial difference with respect to 11 
conventional studies on macroscale droplets,[217] for which the immersion into water phase 12 
depends mainly on the gravitational contribution and less on surface forces. The resulting fL-13 
scale droplets were characterized by impedance[216,218] in which an AC voltage is applied to the 14 
top electrodes within a microfluidic chip (Figure 9B). The resulting differential current 15 
collected from the bottom electrodes is used to measure the size and the amount of the oil 16 
droplets and compared with standard polystyrene beads (Figure 9C). The resulting oil droplet 17 
sizes and speed were in the range comprised between 2-4 μm and 0.15-0.4 m/s, respectively. 18 
Differently from the 6 μm sized polystyrene beads, the small size of the droplets causes the lack 19 
of inertial focusing when flowing in the microchannels (Figure 9D). 20 
5.4.2 Biocompatible scaffolds 21 
Printing Biology approaches derived from 3D printing are employed for building up 22 
biocompatible scaffolds for living cells. The emulation of natural tissues is focused at recreating 23 
the natural “niche” in which cells proliferate. It is known how the natural extracellular matrix 24 
(ECM) tunes intrinsic cellular morphologies and functions, as in the case of stem cells; 25 
unfortunately, ECM complexity limited for long time the possibility for researchers to have a 26 
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valid support for biological studies including regenerative medicine and tissue engineering. 1 
Within this exciting context, 3D printing is a key tool for researchers. The topic has been 2 
recently reviewed by Heinrich et al.[219] Starting from the initial concept of bone tissue 3 
printing,[220] it has been possible to expand this technology to more advanced systems, such as 4 
synthetic cartilage,[221,222] skin,[223] heart valve,[224–226] entire organs,[168,207,227,228] neuronal[229] 5 
and vascular[230,231] networks and supports for medical surgery.[232,233]  6 
The example reported by the team of Prof. McAlpine[234] is an outstanding representation of an 7 
hybrid approach bridging Printing Biology and Bioprinting that leverages 3D printing for 8 
printing bionic objects from inks containing living cells and molecules that tune the ink 9 
physicochemical properties and support the biological systems during the printing process. The 10 
authors prepared a bionic ear by 3D printing a ink containing a cell-seeded alginate hydrogel. 11 
This work (see Figure 10A) has deeply inspired scientists (Surgeons, Chemists, Engineers) to 12 
push further the limits of 3D printing towards artificial organs. In general, the choice of the ink 13 
formulation for 3D printing depends on the viscosity of the printing solution/composite. In this 14 
regard, dichloromethane is a common choice due to the low boiling point and ease to be 15 
removed from the final material;[235] higher boiling point solvents, such as DMSO[236] or 1-16 
methyl-2-pyrrolidinone,[237] are selected when expected deposition from hot solution or an 17 
annealing step has to be performed. Nonetheless, aqueous inks are needed for printing artificial 18 
biosystems, within narrow windows of pH and ionic strength.[238] Additives offer the possibility 19 
to tune rheological properties and stabilization energy due to the interaction of different phases. 20 
Notably, the choice of the scaffold is driven by the final application. However, special focus 21 
has been addressed in recent years to the properties of the resulting scaffold and their correlation 22 
with the printing parameters, especially viscosity and temperature. For example, scaffolds 23 
designed for bone prostheses should possess a uniform pore structure, resembling natural bones 24 
in terms of weight, mechanical profile, and biodegradability. Piperazine-based polyurethane-25 
urea air-driven extrusion 3D printed scaffolds have recently shown great potential, exhibiting 26 
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an interconnected porous structure of about 450 μm in macropore size and about 75% in 1 
porosity.[239] Tuning the mechanical properties is also possible by adjusting piperazine relative 2 
percentage, with the highest contents returning the highest compressive modulus (155.9 ± 5.7 3 
MPa) and strength (14.8 ± 1.1 Mpa). Another route is proposed by De Giglio and coworkers, 4 
whose work discloses the potential of used Filament Fabrication 3D printing.⁠[240] An intricate 5 
compartmentalized bone scaffold has been designed and realized, combining poly(ε-6 
caprolactone) porous scaffold filled with a gellan gum-based hydrogel. Human-TERT 7 
mesenchymal stem cells and human umbilical vein endothelial cells are therein encapsulated 8 
within the gellan gum, revealing high degrees of osteogenic differentiation. Bioactive 9 
nanoparticle/poly(ε-caprolactone) scaffolds have been prepared with hierarchical porous 10 
structures based on solvent evaporation of 3D printed water-in-oil high internal phase emulsion 11 
(HIPE) templates, containing hydrophobically modified hydroxyapatite and silica nanoparticles 12 
in the oil phase.[235] Poly(ε-caprolactone) shows versatility in the design of other human tissues 13 
undergoing mechanical stress; it has been employed as core material for the realization of an 14 
artificial meniscus.[241] The realization of an artificial meniscus is challenging, due to its bizonal 15 
structure; the tissue presents a fibrous outer portion, with a cartilaginous counterpart in the inner 16 
region. The promising approach pursued by Bahcecioglu and co-workers consists in the 17 
preparation of poly(ε-caprolactone) scaffold, impregnated with agarose hydrogels in place of 18 
cartilage, and gelatin methacrylate as porous external layer. The realization of a core-shell 19 
design and the incorporation of fibrochondrocytes into the hydrogels protected the cells from 20 
the mechanical damage. ⁠In a recent work from the group of McAlpine, polymer-based 21 
photodetectors were fully 3D printed by extrusion-based protocols in order to fabricate a bulk 22 
heterojunction formed by P3HT:PCBM photo active layers on a PET film. Such architecture 23 
evolved into an image sensing arrays with high sensitivity and wide field of view, by 3D 24 
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printing interconnected photodetectors directly on flexible substrates and hemispherical 1 
surfaces, (Figure 10B) allowing for a prototype of a bionic eye.[242] 2 
The effects of temperature and viscosity of the 3D printed ink are also of remarkable 3 
importance. Shah and coworkers evidenced how temperature control during the process could 4 
affect the quality of the liquid ink 3D printed scaffold prototype,[243] which consisted in versatile 5 
hyperplastic bones, (Figure 10C) composed of hydroxyapatite and either polycaprolactone or 6 
poly(lactic-co-glycolic acid). They observed that increasing the temperature leads some 7 
materials to lose elasticity and become brittle. In particular, elasticity of those synthetic bones 8 
evolves into plasticity depending on the print rate; that is a negative point for Shah’s purposes, 9 
but could be desirable for other applications. If the previous example is a clear situation where 10 
processability is limited by viscosity, the report offered by Chen and coworkers highlights the 11 
importance of the Young modulus, a quantification of materials stiffness. It is well known how 12 
cells evolves within the nature of the underlying supporting layer,[244] and its stiffness is crucial 13 
for cell survival and proliferation. Chen correctly correlates Young modulus of his 3D printed 14 
blood vessels, iteratively optimizing printing conditions and UV-light exposure times of his 15 
resin, before obtaining the best material.[245] 3D printing can be fruitfully used for the 16 
preparation of an artificial homolog of ECM considering the bioprinting of cell-laden constructs 17 
with novel decellularized extracellular matrix (dECM) bioink, which proved an optimized 18 
microenvironment conducive to the growth of three-dimensional structured tissues.[246]  19 
5.4.3 Bioinspired electronics 20 
Electroactive molecular inks represent an alternative strategy to achieve high control during the 21 
ink deposition, and electrical properties fundamental for the fabrication of bioinspired 22 
electronic devices. Recently, sodium alginate-gated In2O3-gated transistor has been reported in 23 
the literature for the realization of artificial neuronal networks.[247] These printed electronics 24 
were applied for image processing operations, implementing with success color filter 25 
algorithms. The working principle is based on the hydrogenation and hydroxylation of In2O3 26 
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surface, which introduces profound hysteresis properties in the fabricated transistors; then, 1 
hysteresis provides short-term synaptic plasticity capabilities, which can be exploited to imitate 2 
synaptic functions (Figure 11A). An outstanding work has been presented by Lin and 3 
collaborators,[249] who reported the implementation of an all-optical machine learning neural 4 
network based on passive diffractive layer components, patterned using 3D printing techniques. 5 
These layers contributed to the creation of a diffractive multiple-layer array, the key component, 6 
which allowed classifying images of handwritten digits (Figure 11B). A few reports arise in 7 
this cutting-edge area of research, but it is expectable to have an increasing number of research 8 
reports in the near future, along with the evolution of neural regenerative medicine, and the 9 
possibility to develop artificial neural networks along with fully biocompatible matrices.[250,251] 10 
On this respect, Printing Biology could push the development of array systems that have been 11 
actually prepared by unprinted approaches like those by  Restrepo Schild and coworkers 12 
showing the preparation of a soft retina-like system comprising a 4x4 array of macroscale 13 
droplets (200 nL) containing bacteriorhodopsin,[248] and envisaging the potential impact on 14 
neuronal pathways stimulation due to the integration of such bio-array into living tissues. 15 
 16 
6. Conclusions and Perspectives 17 
The realization of artificial biosystems is a topic of enormous interest in life sciences, since 18 
these platforms allow for fundamental understanding of biological processes in tailored cell-19 
like environments. These permit to shed lights on questions related to the origin of life on the 20 
Earth and finally constitute synthetic artificial modules of tunable size and composition that can 21 
be employed for the synthesis and the delivery of biomolecules and chemicals but also for the 22 
development of tissues and organs.  23 
In this Review a critical comparison of the wide spectrum of printing methodologies applicable 24 
to realize artificial biosystems is given. The emerging field, here defined as Printing Biology, 25 
is proposed to result in a technological breakthrough for the field of Synthetic Biology, 26 
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permitting also a direct investigation and manipulation of life-like or life-inspired matter at 1 
tunable dimensional scales and under a plethora of different stimuli (optical, chemical, electrical 2 
and other ones). The Review summarizes the extraordinary progress of printing methodologies, 3 
considering them under a unified view, in order to ascertain the adaptability of these approaches 4 
to different scenarios that can span from those on solids to that into liquids. On solid surfaces, 5 
Printing Biology allows for the fabrication of technologically relevant condensed systems to be 6 
used for the high-throughput programming of biomolecular interaction studies under 7 
multiplexed platforms for applications in drug screening, molecular sensing, artificial biology, 8 
single cells manipulation. In the case of biosystems developed into liquids, Printing Biology 9 
effectively implements the fabrication of artificial compartments as separate cell-like entities 10 
of tunable size and composition, permitting the formation of reconfigurable assemblies that can 11 
be modulated by external triggers such as light, osmolarity, electrical currents. ⁠ 12 
It is important to note that Printing Biology is in its infancy and many different aspects still 13 
need to be optimized. Indeed, by considering the few main printing methods employed for the 14 
nano- (DPN, PPL, HSL), micro- (IJP, µCP), and macro- (stereolithography, extrusion 15 
lithography) scale technologies, it is clear that the number of papers is growing over the last 16 
two decades (see Figure 12A). In particular, the nanoscale printing techniques show a quasi-17 
constant number of published papers per year, as a result of the yet limited equipment and 18 
research laboratories. Differently, a constant increase is observed for microscale printing, due 19 
to the interest in drug screening, cell biology, biosensors. The case of macroscale printing is 20 
still different, since an almost exponential increase is observed from 2015. This because of an 21 
enormously growing interest for 3D printed devices in cellular scaffolds, tissue engineering, 22 
synthetic organs and bioelectronics, this growth being facilitated by the reduction of the 23 
equipment costs with a widespread diffusion in the research laboratories.  24 
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Notably, the development of Printing Biology is currently following three routes. First of all, 1 
the implementation of the printing machine by the installation of printing hardware with 2 
suitable software to finely control a high-resolution operation in the lab. The widespread 3 
diffusion of high-resolution scanning probe related techniques has typically been limited by the 4 
cost of the instrumentation. However, new setups based on microchannels built up on 5 
cantilevers[252] or on 2D arrays of polymeric pens built up onto customized printing[78] would 6 
allow for the reduction of costs and more durable setups. Interestingly, the printers that are 7 
employed at the microscale are less expensive. In fact, the prices of the IJP and 3D printers has 8 
definitely lowered during the last decades, and it is now becoming affordable, also for low 9 
settings. As a second aspect, the optimization of the ink formulations is a crucial point. Here, a 10 
brief overview of the most common materials is reported, especially focusing on DNA, proteins, 11 
phospholipids and polymers-based biological modules. Importantly, each of them necessitates 12 
specific formulation inks suitable for printing which result from an optimization of their 13 
physicochemical properties. Among the considered materials, DNA shows high versatility and 14 
solubility in aqueous solutions. However, more and more studies focus on the employment of 15 
hydrophobic inks, based on phospholipids, proteins or oily substances to mimic cell-like 16 
membranes or primitive life modules. The future researches could possibly implement different 17 
materials within the same ink, in order to fully reconstitute the complex environment of 18 
biological systems. As a third aspect, the possibility to tune printed compartments assembly as 19 
a function of the external inputs can add a higher degree of complexity, paving the way to 20 
important applications in the field of artificial tissues and organs. The resulting artificial 21 
assemblies will need to be investigated also within their interactions with living tissues in order 22 
to fully characterize them as functional biointerfaces for applications in regenerative medicine 23 
and tissue engineering.  24 
In Figure 12B, the applications of printing in selected research fields relevant to Biotechnology 25 
(drug related, cells, artificial organs, scaffolds, tissue engineering and bioelectronics) and other 26 
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non-bio related fields (printed electronics, microfluidics devices, prototyping) are reported as a 1 
function of the above defined nano-, micro-, and macro- scale technologies. As to the field of 2 
Biotechnology, the nanoscale finds applications mainly in drug screening and drug delivery, 3 
the microscale mainly in drug screening and tissue engineering, and finally the macroscale in 4 
cellular scaffolds and tissue engineering. The number of papers in non-bio related fields is 5 
higher with respect to those in the field of Biotechnology for all the different technological 6 
scales. By further developing the field of Printing Biology, it is expected that in the next decade 7 
the actual ratio showed in the Pie chart of Figure 12B between the bio-related applications and 8 
the other non-bio related applications will be significantly increased for all the nano-, micro- 9 
and macro- scale applications. As an example, Printing Biology assembled devices could find 10 
important applications in the emerging field of Biocomputing, a discipline that employs 11 
molecular biology modules like gene circuits as the hardware to implement bio-inspired 12 
computer devices.[253]  13 
Future researches efforts would fully exploit the potentialities of Printing Biology opening up 14 
the definition of new multiscale patterning protocols by coupling different printing techniques 15 
and ink formulations, along with the engineering of new artificial biosystems based on 16 
biological and non-biological materials which could be interfaced with living systems or could 17 
instead be designed as stand-alone systems with enhanced properties.  18 
 19 
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 1 
Figure 1. A schematic picture showing the key feature of Printing Biology consisting of high-2 
resolution printing heads, employing engineered molecular inks (e.g. DNA, phospholipids, 3 
proteins) to build up artificial biosystems (on-solids, into-liquids), including all those life-like 4 
or life-inspired structures showing a biological behavior, from small condensates, up to 5 
compartments, networks, tissues and organ-like constructs. In this way, Printing Biology 6 
intersects the field of the bottom-up Synthetic Biology. 7 
 8 
 9 
 10 
Figure 2. Main printing methods allowing delivering size tunable molecular inks onto solids or 11 
into liquids.  12 
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 1 
 2 
Figure 3. Physical mechanisms of inks deposition. (A) Diffusive molecular ink deposition by 3 
Dip Pen Lithography onto solid surfaces. (B) Liquid ink deposition by Dip Pen Lithography 4 
onto solid surfaces. (C) Liquid ink deposition by Polymer Lithography onto solid surfaces. 5 
Notably, ΔPtip and ΔPm identify the Laplace gradient between the ink-tip and the ink-air 6 
menisci, respectively. (D) Microscale ink droplet deposition onto solid supports. The 7 
parameters m and U identify the mass and the velocity of the impacting droplet. ΔEu is the 8 
dissipated energy by viscosity during the droplet impact; σlv, σls and σsv identify the liquid-9 
vapor, liquid-solid and solid-vapor surface energies, respectively. (E) Microscale aqueous ink 10 
droplet deposition onto immiscible oil-droplet; σov , σwv  and σow  represent the oil-vapor, 11 
water-vapor and oil-water surface energies, respectively. (F) Microscale oil ink droplet 12 
deposition onto immiscible aqueous droplet;  σo′v, σwv , σo′w represent the oil-vapor, water-13 
vapor and oil-water surface energies, respectively. The terms ρw, ρo and ρo’ identify the densities 14 
of the aqueous ink and of the two different oils, respectively. 15 
 16 
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 1 
Figure 4. Printed DNA-rich condensates on solids. (A-B) DPN coupled with DDI allows the 2 
generation of live-cell arrays for the recruitment of transmembrane EGFR receptors on MCF 7 3 
cells. Scale bar is equal to 5 µm. Reproduced with permission from Ref.[131] Copyright © 2013 4 
WILEY‐VCH. (C) i) Multiplexed antibodies microarrays by coupling DPN and DDI. ii) COS7 5 
cells expressing bait‐PARCs, which display VSV‐G epitope tags, are recruited to anti‐VSV‐G 6 
functionalized microarray. iii) COS7 cells expressing two bait‐PARCs, which display the 7 
corresponding peptide epitope tags (HA and VSV‐G) in their extracellular region onto anti‐8 
VSV‐G and anti‐HA. Scale bar is equal to 5 µm in ii) and equal to 10 microns in iii). Reproduced 9 
with permission from Ref.[130] Copyright © 2014 WILEY‐VCH.  (D) EGFR activation on 10 
MCF7 cells by EGF ligands is detected by the increased phosphorylation of EGFR at Tyrosine 11 
residue 1068 in subcellular regions at interface with EGF-rich microspots. Reproduced with 12 
permission from Ref.[78] Copyright © 2014 WILEY‐VCH.  13 
 14 
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 1 
Figure 5. Printed phospholipid-rich condensates on solids. (A) Scheme of phospholipid 2 
complex microarrays deposited by DPN: (i) patterns of different color represent drugs loaded 3 
at the phospholipid interface, and the relative zoom shows the microarrays constituting each 4 
pattern; (ii) phase contrast and fluorescence images overlay of a rhodamine-DOPE/DOTAP 5 
pattern, and (iii) its application as surface-mediated delivery system at NIH 3T3 cells interface. 6 
The white arrows indicate the printed area borders and evidence the absence of solution-7 
mediated drug delivery. Reprinted from Ref.[148] Copyright (2012), with permission from 8 
Elsevier. (B) L-DPN-based platform for extracellular receptor recruitment: (i) scheme of the 9 
binding assay, (ii) array of rhodamine-PE and DNP-PE mixture, and (iii) mast cells RBL 2H3 10 
showing co-localization of the cell bound Alexa Fluor 647-labelled anti-dinitrophenol IgE AB 11 
(AF647-αDPN IgE) with the allergen/lipid pattern. Scale bars 50 µm. Reproduced from Ref.[136] 12 
under the terms of the Creative Commons Attribution Non-Commercial License.  13 
 14 
 15 
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 1 
Figure 6. Printed microscale aqueous compartments on solids. (A) Fabrication of 2 
polyelectrolyte multilayer (PEM) based on µCP. (B) PEM microplates can be rolled up to 3 
intermediate rolling stages from to microtubes resulting microrockets (C) can travel around 4 
straight trajectories upon propulsion, as reported in the  (i)-(iv), reaching speed higher than 50 5 
μm/s. Scale bars: 20 μm. Reproduced with permission from Ref.[182] Copyright © 2018 by John 6 
Wiley and Sons, Inc. Reprinted with permission from John Wiley and Sons, Inc. (D) IJP-based 7 
drug screening platform based on colorimetric detection of surface immobilized glucose 8 
oxidase with glucose at solid/liquid interface. Reaction occurs in spot 1, whereas it is inhibited 9 
in spot 2, due to the presence of the inhibitor D-glucal in the printed droplet. (E) Colorimetric 10 
signal extraction from single spots. Reprinted with permission from Ref.[69] Copyright 2010 11 
American Chemical Society. (F) IJP-based fabrication of a microarray containing model 12 
biological membranes onto solid substrates. (G) Brightfield and fluorescence images of the 13 
printed droplets of the printed phospholipids. Reprinted with permission from Ref.[192] 14 
Copyright 2013 American Chemical Society. 15 
 16 
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   1 
Figure 7. Printed microscale aqueous compartments into liquids. (A) (i) IJP protein-rich 2 
aqueous compartments containing mixtures of streptavidin (STV) - fluorolabeled biotin 3 
(BTN*) at nL-scale. (ii) IJP allows tuning the aqueous compartment volume from 102 to 10-1 4 
nL. (B) The model STV-BTN* binding interaction is investigated in the compartments by 5 
RICS, permitting to obtain the differences on the diffusion coefficient between the free BTN* 6 
and the STV-BTN* complex (i) and the effect of the droplet volume (ii). Republished with 7 
permission from the Royal Society of Chemistry, from Ref.[95]; permission conveyed through 8 
Copyright Clearance Center, Inc. (C) IJP fL-scale compartments printed inside mineral oil 9 
droplets (i) with crowding effects at water/oil interfaces (ii); the droplets are assembled at the 10 
water/oil interface and (iii) autonomous molecular adsorption at the water/oil interface is 11 
observed. (D) Model mitochondrial reaction (i) consisting in the EOMCC conversion to form 12 
CHC and (ii) DNA hairpin conformational change to double strand DNA can be successfully 13 
carried out within the compartments. Reproduced from Ref.[85] (E) IJP-based formation of 14 
single lipid vesicles at liquid/liquid interfaces. The pauses between pulses determine the 15 
frequency of vesicle formation. (F) The formation of pL-sized phospholipid vesicles is possible 16 
by tuning the shear rates during the membrane collapse by increasing the viscosity of the 17 
solution in which the phospholipid membranes are formed. Scale bar is equal to 50 µm. 18 
Reproduced with permission from the Royal Society of Chemistry, from Ref.[201] ; permission 19 
conveyed through Copyright Clearance Center, Inc.  20 
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 1 
 2 
 3 
Figure 8. Printed aqueous compartments networks: towards synthetic tissues. (A) 4 
Fabrication of tissue-like soft materials by printing aqueous droplets of about ∼65 pL volume 5 
into a solution of lipids in oil. The staphylococcal α-hemolysin (αHL) was added to favor 6 
electrical conductivity between the droplets. (B) When droplets at different osmolarities (i) are 7 
joined by a lipid bilayer, the resulting flow of water through the bilayer causes swelling or 8 
shrinking of the droplets (ii). The orange and blue droplets contained 250 mM KCl and 16 mM 9 
KCl, respectively. Scale bar, 250 µm. Figures reproduced from Ref.[202] Reprinted with 10 
permission from AAAS. (C) UV-triggered protein expression system. UV light allows the 11 
cleavage of the photocleavable biotin linkers that bind streptavidin to DNA, permitting the T7 12 
RNA polymerase to bind the LA-T7 promoter, allowing the gene transcription. (D) Scheme (i) 13 
and optical images (ii) of the light-activated expression of LA-mVenus in synthetic cells and 14 
synthetic tissues. (E) Patterned control of the protein expression in synthetic tissues (i). Optical 15 
image of the synthetic compartments expressing mVenus. Figure reproduced from Ref.[204] 16 
under the terms of the Creative Commons Attribution Non-Commercial License. 17 
 18 
 19 
 20 
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Figure 9. Printed primitive microscale compartments. (A) IJP water-immiscible pL-scale 1 
oil droplets into a surfactant laden water phase leads to the spontaneous fragmentation leading 2 
to the formation of fL-scale oil droplets dispersed in the aqueous phase. (B) Electrical detection 3 
of single oil droplets by a microfluidic impedance chip. (C) Single oil droplets are detected in 4 
a microfluidic chip by observing the electrical impedance variations in the flowing aqueous 5 
phase. (D) (i) Size and (ii) velocity profile of the droplets lead to the emergence of a scenario 6 
in which the oil droplets lack from field focusing effects, due to their small sub-cellular scale. 7 
Reprinted with permission from Ref.[216] Copyright (2019) American Chemical Society. 8 
 9 
 10 
 11 
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 1 
  2 
Figure 10. Progress towards 3D printed tissues and organs. (A) Manufacturing steps to 3 
generate a bionic ear. From left to right, (i) CAD drawing of the bionic ear, (ii) panoramic view 4 
of the printed functional materials and the 3D printed employed for the printing process, (iii) 5 
the 3D printed bionic ear immediately after printing, iv) the 3D printed bionic ear during in 6 
vitro culture. Reproduced with permission from Ref.[234] Copyright 2013, American Chemical 7 
Society. (B) 3D‐printed photodetector arrays printed on planar and spherical surfaces. From left 8 
to right, (i) photodetector array printed on PET films, (ii) letter "M" optical patterns projected 9 
onto the photodetector array and the reconstructed image, (iii) photographs of the concentric 10 
photodetector array printed onto the inner surface of a hemispherical glass dome. Reproduced 11 
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with permission from Ref.[242]⁠ Copyright 2018, WILEY‐VCH. (C). 3D printed hyperplastic 1 
bones, composed of hydroxyapatite and either polycaprolactone or poly(lactic-co-glycolic 2 
acid). Several possible designs are presented, and the hypothetical route from CAS drawing 3 
until the pre-surgical prototype. Reproduced with permission from Ref.[243] Copyright 2016, 4 
AAAS. 5 
 6 
 7 
 8 
 9 
Figure 11. Printed artificial neural networks. (A) Schematic representation of the fully 10 
solution-processed synaptic network using metal salt combustion precursors and the transistor 11 
morphology. An example of implemented color filtering algorithm is herein shown for a 12 
photogram depicting a ladybug on a leaf. Reproduced with permission from Ref.[247] Copyright 13 
2019, American Chemical Society. (B) Diffractive deep neural networks (D2NNs) comprising 14 
multiple transmissive (or reflective) layers, where each point on a given layer acts as a neuron, 15 
with a complex-valued transmission (or reflection) coefficient. In details, the experimental 16 
design for the machine learning apparatus, a representative image of the classifier D2NN (for 17 
handwritten digits and fashion products) and the amplitude imaging D2NN. Reproduced with 18 
permission from Ref.[249]⁠ Copyright 2018, AAAS. 19 
 20 
 21 
 22 
 23 
 24 
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 1 
 2 
Figure 12. Applications of Printing Technologies. (A) Number of published papers from 3 
1999 to 2019 on nanoscale printing (black squares), microscale printing (red dots) and 4 
macroscale printing (green triangles). (B) Pie chart of the major applications of printing 5 
technologies for six target bio-related applications (artificial organs, bioelectronics, cells, drugs, 6 
scaffolds, tissue engineering) and other technological relevant sectors (printed electronics, 7 
microfluidics devices, prototyping technology). Data extracted from the Scopus database.   8 
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Table 1. Major contact nanoscale printing methodologies, molecular ink features 1 
(molecules/biomolecules, additives, sizes) and some bio-related applications onto solid 2 
surfaces. *DDI stands for DNA directed immobilization, a technique which employs surface-3 
bound capture oligonucleotides for selectively binding biomolecules tagged with 4 
complementary oligomeric sequences.[143] 5 
 6 
Printing 
Methodology 
Printed 
Molecules/Biomolecules 
Added Additives Droplet Size Main Features Ref. 
Dip Pen 
Lithography 
 
 
 
 
 
Oligonucleotides 
 
PEG 
 
100 µm 
 
Protein immobilization  
by DDI* 
 
[131] 
 
Oligonucleotides 
 
- 
102 µm 
 
DNA sequences 
immobilization  
on thermoplastic polymers 
[254] 
Oligonucleotides 
 
Trehalose 
 
102 µm 
 
Protein immobilization  
by DDI 
 
[255] 
Oligonucleotides 
 
- 
 
102 µm 
 
Protein immobilization  
by DDI 
 
[256] 
Oligonucleotides 
 
Glycerol 
 
PEG 
 
101 µm 
 
Protein immobilization  
by DDI 
 
[130] 
Thermoresponsive 
Polymers 
 
- 
101 µm 
 
Thermosensitive cell 
support 
 
[257] 
Phospholipids 
 
- 
100 - 101 µm 
 
Supported Phospholipid 
Patterns 
 
[147] 
Phospholipids 
 
- 
10-1 - 100 µm 
 
Combination with µCP 
 
[150] 
Phospholipids 
Drug 
 
- 
101 - 102 µm 
 
Surface-mediated 
 drug delivery 
 
[148] 
Fluorescent Dyes 
Mineral Acids and Bases 
Transition Metal Salts 
Enzymes 
 
Glycerol 
 
Diethyleneglycol 
 
101 µm 
 
Chemical reactions 
at the fL-scale 
 
[258] 
Organic Azides 
 
Glycerol 
 
5 µm 
 
Protein immobilization  
by click-chemistry 
  
[259] 
 
ECM Proteins 
Fluorescent Dyes 
 
Printing Buffer 
 
101 µm 
 
Surface-mediated dye 
delivery into arrays of cells  
 
[260] 
Multiple 
Probe 
Lithographies 
 
Oligonucleotides  
 
 
Glycerol 
 
Tween-20 
 
101 µm 
 
Protein immobilization by 
DDI 
 
[78] 
Oligonucleotides  
 
Trehalose  Detection of fungal 
pathogen 
[137] 
PEG derivatives 
 
- 
100 µm 
 
ECM protein 
immobilization  
by chemisorption 
[261] 
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Phospholipids 
 
- 
100 - 101 µm 
 
Phospholipid pattern 
functionalization with DNA 
Origami 
 
[262] 
 
Phospholipids 
 
- 
100 - 101 µm 
 
Gradient patterns of 
phospholipids 
[135] 
Phospholipids 
 
- 
101 µm Cells recruiting  
by immobilized protein 
[136] 
Thiols 
- 
10-1 - 100 µm 
 
Diffraction Gratings 
Fabrication 
[263] 
Thiols 
- 
100 µm 
 
Patterning on gold 
surfaces 
[264] 
 1 
  2 
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Table 2. Major non-contact printing methodologies, molecular ink features 1 
(molecules/biomolecules, additives, sizes) and some relevant bio-related applications onto 2 
solids or into liquids.  3 
 4 
Printing 
Methodology 
Printed 
Molecules/Biomolecules 
Added Additives Droplet Size Applications Ref.  
Microcontact 
Printing 
Oligonucleotides 
 
 
 
 
biotin thiol, mannose thiol, 
and tetraethylene glycol 
thiol  
 
 
 
Chitosan/alginate 
polyelectrolyte multilayer 
microsized films  
30 mM sodium 
acetate buffer; 10% 
DMSO 
 
 
α,α-dimethoxy-α- 
phenylacetophenone 
 
 
 
 
/  
101 µm 
 
 
 
 
 
101 µm 
 
 
 
 
 
101 µm 
 
 
DNA directly patterned 
on glass surfaces 
 
 
 
Lipidic vesicles 
containing amphiphilic β-
cyclodextrin 
 
 
 
Fabrication of polymer 
multilayer plate 
micromotors 
[180] 
 
 
 
 
 
[181] 
 
 
 
 
[182] 
 
 
Inkjet 
Printing 
 
 
 
 
 
Oligonucleotides 
 
2-Hydroxyethyl 
methacrylate; 
Phosphoramidite 
101 µm 
 
Coupling of of DNA 
oligonucleotide synthesis 
with DNA origami 
technology 
[185][131] 
 
Proteins 
 
10- 50% w/v glycerol 
 
101 µm 
 
Glucose oxidase 
monolayer at silicon 
dioxide surface 
[69] 
Proteins 
 
DMSO/glycerol (9:1) 
 
102 µm 
 
DMSO-rich liquid 
compartments 
 
 
[187] 
Proteins 
 
30% w/v glycerol 
 
102 µm 
 
Glycerol-rich liquid 
compartments 
 
[188] 
Lipids 
2-bis(10,12-
tricosadiynoyl)-sn-glycero-
3-phosphocholine 
(DiynePC) 
 
Fluorophore (0.1 
mM), and 5% (v/v) 
glycerine. 
101 µm 
 
Phospholipid bilayers at 
solid/liquid interface 
 
[192] 
Lipids 
1,2-dipalmitoyl-sn-glycero-
3-phosphocholine;  
1,2-dioleoyl-sn-glycero-3-
phosphocholine 
 
Polysorbate 20; 
cholesterol 
101 µm 
 
Single-cell Raman 
calibration standard 
 
[193] 
Proteins 
 
polyoxyethylene (20) 
sorbitan 
monolaurate 
101 – 102 µm 
 
pL- to nL- scale  
aquoeus compartments 
by inkjet printing 
 
[95] 
DNA hairpin, Proteins 
 
 
polyoxyethylene (20) 
sorbitan 
monolaurate and 
poly(ethylene 
glycol)-block-
poly(propylene 
glycol)-block-
poly(ethylene glycol) 
100 – 101 µm 
 
fL-scale aquoeus 
compartments by inkjet 
printing 
 
[85] 
Egg phosphatidylcholine 
and poly(2-vinyl- pyridine-
b-ethyleneglycol)  
 
Ethanol 
10-1 µm 
 
Direct formation of lipid 
and polymer vesicles 
 
.[200] 
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Phospholipids in aqueous 
phase 
 
7.5 w/v% ficoll 400; 
300 mM glucose 
solution 
102-3 µm 
 
Unilamellar lipid vesicles 
by inkjet printing 
[201] 
Alkaline phosphatase, 
Urease, β-lactamase  
Glycerol (5 w/w%) in 
10 mM PBS  
 
102 µm 
 
Protein immobilization  
in printed hydrogels 
 
    [190]   
Lipidoids  
Aqueous sodium 
acetate buffer 
102-3 µm 
 
Surface-mediated 
molecular delivery into 
arrays of cells  
 
[191] 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
 29 
 30 
 31 
 32 
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Table 3. Major 3D Printing reported examples for the realization of molecular ink features (molecules/biomolecules, solvent(s), additives, printing 
rate) and some relevant bio-related applications (artificial organs, scaffolds, tissue engineering). The abbreviation n.r. stands for not reported. 
 
 
 
Application field(s) Environment Solvent(s) Printed  
Molecule(s)/ Biomolecule(s)/ matrix(es) 
Added Additive(s) Printing rate Ref. 
Artificial electric organs Aqueous H2O Acrylamides w/ and w/o glycerol. Photoinitiator n.r. [212] 
Biocompatible scaffolds 
 
Aqueous H2O / DMSO Poly(ethylene glycol)/ poly(D,L-lactide) Cross-linking inhibitor, dye, 
photoinitiator 
Stereolithography  [170] 
Biocompatible scaffolds Aqueous H2O Poly(ethylene glycol)/diacrylate hydrogel Photoinitiator Stereolithography  [172] 
Biocompatible scaffolds Aqueous Phosphate buffer solution 
/ DMSO 
Gelatin methacrylate hydrogel/ poly(ethylene glycol)-
diacrylate  
4-Dimethylaminopyridine, photo-
iniziator, 1-Vinyl-2-pyrrolidinone 
Stereolithography  [165] 
Biocompatible scaffolds 
(hollow tubules) 
Aqueous - H2O 
- H2O 
- Sodium alginate 
- Alginate / gelatin / glutaraldehyde / polyacrylamide 
binary combinationshydrogels 
- Cross-linking agent 
- / 
-       20 μL/min 
- 5 ÷ 20 μL/min 
[174] 
Compartmentalized 
reactive systems 
Aqueous 
 
- Dextran 
- PEG 
- Poly(diallyldimethylammonium chloride) 
- Poly(sodium 4-styrenesulfonate) 
/ 100 ÷ 4k mm/min [205] 
Tissue engineering Aqueous Phosphate buffer solution Poly(ε-caprolactone) / adipose, cartilage or heart 
decellularized extracellular matrices 
/ n.r. [246] 
Tissue engineering 
(bone, vascular network) 
Aqueous Phosphate buffer solution - Collagen 
- FITC-alginate  
- Fibrinogen 
Hyaluronic acid, albumin n.r. [210]  
Tissue engineering 
(cartilage) 
Aqueous H2O Nanofibrillated cellulose Alginate, cross-linking agent, D-
Mannitol  
10 ÷ 20 mm/sec [221] 
Tissue engineering 
(ear / cartilage) 
Aqueous Phosphate buffer solution Alginate hydrogel matrix/chondrocytes Antibiotics / antimycotic, silicone, 
silver nanoparticles 
0.42 mL/min [234] 
Tissue engineering 
(heart valve) 
Aqueous Acidic or basic aqueous 
medium 
- Alginate 
- Collagen  
- Collagen (acidic solution) 
Dye, photoinitiator, 3 ÷ 23 mm/s [211] 
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- Fibrinectin 
- Methacrilated hyaluronic acid  
 
Tissue engineering 
(heart valve) 
Aqueous Phosphate buffer solution Poly(ethylene glycol)-diacrylate Photoinitiator Stereolithography  [224] 
Tissue engineering 
(neural network) 
Aqueous Buffered aqueous solution Human induced pluripotent stem cells (hiPSCs)/ 
alginate/ Chitosan/ fibrin/ genipin 
/ n.r. [229] 
Tissue engineering 
(neural network) 
Aqueous Buffered aqueous solution Human neural stem cells (hNSCs)/Agarose/ 
carboxymethylchitosan/ polysaccharides alginate 
Cross-linking agent n.r. [250] 
Tissue engineering 
(skin) 
Aqueous Human plasma Human fibroblasts and keratinocytes Cross-linking agent 2.85 cm2/min [265] 
Tissue engineering 
(vascular network) 
Aqueous Collagen hydrogel Human umbilical vein endothelial cells (HUVECs) / n.r. [231] 
Tissue engineering 
(vascular network) 
Aqueous - H2O 
- H2O 
- 10% gelatin mixture 
- collagen 
/ 
/ 
n.r. [230] 
Tissue engineering 
(vascular network) 
Aqueous Basic buffer solution Dopamine/ Hydroxylethyl methacrylate Curing agent, photoiniziators Stereolithography  [245] 
Tissue engineering 
(vascular network) 
Aqueous Basic buffer solution Cell-laden silicon ink  Pluronic F127  1 ÷ 50 mm/sec [175]  
Tissue engineering 
(vascular network) 
Aqueous H2O PEGDA Dyes, photoinitiator, metal 
nanoparticles  
Stereolithography [173]  
Tissue engineering 
(vascular network) 
Aqueous Phosphate buffer solution Gelatin solution / Stereolithography [209]  
- Biocompatible scaffolds 
-     Drug delivery carriers 
Biphasic H2O / CH2Cl2 Poly(ε-caprolactone)/   hydroxyapatite and silica 
nanoparticles 
Nanoparticles surface modifier 30 mm/sec [235] 
Tissue engineering Biphasic H2O / hexadecane/ 
silicone oil 
1,2-Diphytanoyl-sn-glycero-3-phosphocholin Dyes 200 μm/sec [202] 
Biocompatible scaffolds Organic THF / Tripropylene Glycol 
Monomethyl Ether 
Methyl-silsesquioxane resin/ 3-(trimethoxysilyl) 
propyl methacrylate 
Photoinitiators Stereolithography  [171] 
Biocompatible sensors Organic - 1-methyl-2-pyrrolidinone 
- m-Xylene 
- Poly(methyl methacrylate) 
- Silver nanoparticles 
- / 
- / 
10 mm/sec [237] 
Synthetic tissue Organic Hexadecane/silicone oil diphytanoyl phosphatidylcholine /1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine-N-[methoxy(poly- 
ethylene glycol)-2000] 
/ n.r. [204] 
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Tissue engineering 
(bone) 
Organic neat Cyracure® - UVR-6105/ hydroxyapatite powder Photoinitiator Stereolithography  [167] 
Tissue engineering 
(bone) 
Organic CH2Cl2 / 2-butoxyethanol / 
dibutyl phthalate 
Hydroxyapatite/Polycaprolactone or 
Hydroxyapatite/poly(lactic-co-glycolic acid) 
/ 15 cm/sec [243] 
Tissue engineering 
(bone) 
Organic 1,4-dioxane Polyurethane/ urea scaffolds Piperazine n.r. [239] 
Tissue engineering 
(bone) 
Organic neat Poly(propylene fumarate) Cross-linking inhibitor, 
photoiniziator 
Stereolithography  [168] 
Tissue engineering  
(bone) 
Organic neat Poly(ε-caprolactone) / 25 mm/min [240] 
Tissue engineering 
(bone) 
Organic CHCl3/ DMSO Mesoporous bioactive glass/ poly(3-hydroxybutyrate-
co-3-hydroxyhexanoate) 
/ 4 ÷10 mm/sec [236] 
Tissue engineering 
(bone, ear, skelet. muscle) 
Organic neat Poly(ε-caprolactone) DMEM, gelatin, fibrinogen, 
hyaluronic acid, trombin  
0.4 µL/sec [208]  
Tissue engineering 
(cartilage) 
Organic neat Acrylonitrile butadiene styrene/ poly(L-lactic acid) / n.r. [222] 
Tissue engineering 
(eye) 
Organic - Toluene 
- Chlorobenzene 
- MDMO/PPV 
- P3HT/PCBM 
/ 
/ 
0.5 ÷ 5 mm/sec [242] 
Tissue engineering 
(heart valve) 
Organic - neat 
- neat 
- CarboSil® 80A 
- Estane® 58226 
/ 
/ 
1000 mm/min [226] 
Tissue engineering 
(meniscus) 
Organic DMSO Cellulose nanocrystals/ Phenyl acrylate / Acrylamide 
/ N,N′-methylenebis(acrylamide) 
Photoinitiator 2 mm/sec [166] 
Tissue engineering 
(meniscus) 
Organic neat Poly(ε-caprolactone) / Stereolithography  [241] 
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Printing Biology employs different technologies dispensing molecular inks with tunable 
composition (molecules, polymers, biomolecules) and drop sizes (from nano- up to macro- 
scale) onto solids or into liquids to develop life-like or life-inspired artificial biosystems (from 
small condensates, to compartments up to networks, tissues and organs). This work reviews the 
extraordinary potential of this emerging research field. 
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